<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d2 20140930//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Retrovirology</journal-id><journal-id journal-id-type="iso-abbrev">Retrovirology</journal-id><journal-title-group><journal-title>Retrovirology</journal-title></journal-title-group><issn pub-type="epub">1742-4690</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4567795</article-id><article-id pub-id-type="publisher-id">204</article-id><article-id pub-id-type="doi">10.1186/s12977-015-0204-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4<sup>+</sup> T-cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Nitasha A.</given-names></name><address><email>nitasha.kumar@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Cheong</surname><given-names>Karey</given-names></name><address><email>karey.cheong@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Powell</surname><given-names>David R.</given-names></name><address><email>david.powell@monash.edu</email></address><xref ref-type="aff" rid="Aff3"/><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>da Fonseca Pereira</surname><given-names>Candida</given-names></name><address><email>candida.d.f.pereira@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Anderson</surname><given-names>Jenny</given-names></name><address><email>jenny.anderson@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Evans</surname><given-names>Vanessa A.</given-names></name><address><email>vanessa.evans@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author"><name><surname>Lewin</surname><given-names>Sharon R.</given-names></name><address><email>sharon.lewin@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Cameron</surname><given-names>Paul U.</given-names></name><address><email>paul.cameron@unimelb.edu.au</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff2"/><xref ref-type="aff" rid="Aff5"/></contrib><aff id="Aff1"><label/>Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, VIC 3004 Australia </aff><aff id="Aff2"><label/>Centre for Biomedical Research, Burnet Institute, Melbourne, VIC 3004 Australia </aff><aff id="Aff3"><label/>Victorian Life Science Computational Initiative, Parkville, 3010 Australia </aff><aff id="Aff4"><label/>Monash Bioinformatics Platform, Monash University, Clayton, 3800 Australia </aff><aff id="Aff5"><label/>Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, 3010 Australia </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>12</volume><elocation-id>76</elocation-id><history><date date-type="received"><day>13</day><month>4</month><year>2015</year></date><date date-type="accepted"><day>1</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Kumar et al. 2015</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Combination antiretroviral therapy (cART) is able to control HIV-1 viral replication, however long-lived latent infection in resting memory CD4<sup>+</sup> T-cells persist. The mechanisms for establishment and maintenance of latent infection in resting memory CD4<sup>+</sup> T-cells remain unclear. Previously we have shown that HIV-1 infection of resting CD4<sup>+</sup> T-cells co-cultured with CD11c<sup>+</sup> myeloid dendritic cells (mDC) produced a population of non-proliferating T-cells with latent infection. Here we asked whether different antigen presenting cells (APC), including subpopulations of DC and monocytes, were able to induce post-integration latent infection in resting CD4<sup>+</sup> T-cells, and examined potential cell interactions that may be involved using RNA-seq.</p></sec><sec><title>Results</title><p>mDC (CD1c<sup>+</sup>), SLAN<sup>+</sup> DC and CD14<sup>+</sup> monocytes were most efficient in stimulating proliferation of CD4<sup>+</sup> T-cells during syngeneic culture and in generating post-integration latent infection in non-proliferating CD4<sup>+</sup> T-cells following HIV-1 infection of APC-T cell co-cultures. In comparison, plasmacytoid DC (pDC) and B-cells did not induce latent infection in APC-T-cell co-cultures. We compared the RNA expression profiles of APC subpopulations that could and could not induce latency in non-proliferating CD4<sup>+</sup> T-cells. Gene expression analysis, comparing the CD1c<sup>+</sup> mDC, SLAN<sup>+</sup> DC and CD14<sup>+</sup> monocyte subpopulations to pDC identified 53 upregulated genes that encode proteins expressed on the plasma membrane that could signal to CD4<sup>+</sup> T-cells via cell&#x02013;cell interactions (32 genes), immune checkpoints (IC) (5 genes), T-cell activation (9 genes), regulation of apoptosis (5 genes), antigen presentation (1 gene) and through unknown ligands (1 gene).</p></sec><sec><title>Conclusions</title><p>APC subpopulations from the myeloid lineage, specifically mDC subpopulations and CD14<sup>+</sup> monocytes, were able to efficiently induce post-integration HIV-1 latency in non-proliferating CD4<sup>+</sup> T-cells in vitro. Inhibition of key pathways involved in mDC-T-cell interactions and HIV-1 latency may provide novel targets to eliminate HIV-1 latency.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12977-015-0204-2) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Dendritic cells</kwd><kwd>Monocytes</kwd><kwd>B-cells</kwd><kwd>HIV Latency</kwd><kwd>Resting CD4<sup>+</sup> T-cells</kwd><kwd>Antigen presenting cells</kwd><kwd>APC</kwd><kwd>Viral reservoir</kwd><kwd>Latency induction</kwd><kwd>Post-integration latency</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>Despite the successes of cART in the reduction of morbidity and mortality world wide, treatment is required life long. HIV-1 persists in individuals on cART in resting CD4<sup>+</sup> T-cells as latent infection [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref>]. Latency occurs when viral DNA is integrated within the host genome and remains transcriptionally silent. Latent infection of resting CD4<sup>+</sup> T-cells therefore represents the major barrier to HIV-1.</p><p>It remains unclear how latency is established in resting CD4<sup>+</sup> T-cells in vivo. Initial studies in vitro, showed that direct HIV-1 infection of resting CD4<sup>+</sup> T-cells isolated from peripheral blood was inefficient and integration rarely occurred due to incomplete reverse transcription, reduced nuclear import of the viral DNA and/or limited integration within the host genome [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. However, in vitro latent infection can occur following the reversion of a HIV-1 infected, activated CD4<sup>+</sup> T-cell to a resting state [<xref ref-type="bibr" rid="CR7">7</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>]. Alternatively, latent infection can also occur following the direct infection of a resting CD4<sup>+</sup> T-cell exposed to high viral titers and spinoculation [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], chemokines [<xref ref-type="bibr" rid="CR13">13</xref>] or co-culture with other cell types [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p><p>As professional APCs, DC interact with HIV-1 during initial infection at vaginal and rectal mucosa sites and in blood. Langerhan cells (LC) and dermal (D)DC at mucosa and, bone marrow derived classical or myeloid (m)DC and plasmacytoid (p)DC in blood are able to interact with T-cells, but their role in the establishment and maintenance of HIV-1 latency remain unclear [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. Blood derived mDC subpopulations differ from tissue DC. CD141<sup>+</sup> and CD1c<sup>+</sup> mDC are both found as resident cells in tissue (lymph node (LN), spleen, lungs), skin and, as more mature cells, circulating through the lymphatics to the LN [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR22">22</xref>]. SLAN<sup>+</sup> DC represent a subpopulation of monocytic cells with increased potential to secrete pro-inflammatory cytokines and develop a DC phenotype, however precise residence remains unknown [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. CD14<sup>+</sup> monocytes represent DC and macrophage precursors in blood [Reviewed in <xref ref-type="bibr" rid="CR25">25</xref>], and were also tested for their ability to establish latent infection in resting CD4<sup>+</sup> T-cells.</p><p>We have previously developed an in vitro co-culture model demonstrating that CD11c<sup>+</sup> myeloid dendritic cells (mDC) induce post-integration latency in non-proliferating memory CD4<sup>+</sup> T-cells. Here we demonstrate that in addition to the mDC subsets (CD1c<sup>+</sup>, SLAN<sup>+</sup> and CD141<sup>+</sup>), CD14<sup>+</sup> monocytes were also able to induce post-integration HIV-1 latency in non-proliferating CD4<sup>+</sup> T-cells. In comparison, T-cells co-cultured with pDC and B-cells were inefficient in the induction of latency. Using RNA-seq and Illumina gene expression microarrays, we also identified potential mediators of latent infection expressed by APC that could induce latency in the non-proliferating CD4<sup>+</sup> T-cells during APC-T cell interactions.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Monocytes are able to induce latency in resting CD4<sup>+</sup> T-cells</title><p>We have previously reported that mDC, but not pDC, are able to efficiently induce post-integration latent infection in resting CD4<sup>+</sup> T-cells using an in vitro DC-T-cell co-culture model [<xref ref-type="bibr" rid="CR14">14</xref>]. However, mDC and their subpopulations represent only a small proportion of peripheral blood mononuclear cells (PBMC) compared to monocytes, which represent a precursor to some DC and macrophage subpopulations. Therefore we compared monocytes and mDC isolated from healthy donors for their ability to induce latent infection in resting CD4<sup>+</sup> T-cells (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). eFluor670 labeled resting CD4<sup>+</sup> T-cells were cultured alone, with CD11c<sup>+</sup> mDC or bulk monocytes and infected with an R5 using virus that expresses enhanced green fluorescent protein (EGFP). Similar to mDC, monocytes were able to induce productive infection in CD4<sup>+</sup> T-cells, as measured by total EGFP expression at day 5 post-infection (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>b). At day 5 post-infection non-proliferating (eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup>) CD4<sup>+</sup> T-cells were sorted and cultured with phytohemagglutinin (PHA)-stimulated feeder peripheral blood mononuclear cells (PBMC), where the number of EGFP<sup>+</sup> cells was quantified by flow cytometry as a surrogate marker of inducible latent infection. CD14<sup>+</sup> monocytes were also able to significantly increase the induction of latent infection in non-proliferating cells (p&#x000a0;&#x0003e;&#x000a0;0.05; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>c).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Monocyte induced latency in non-proliferating CD4<sup>+</sup> T-cells. <bold>a</bold> Resting CD4<sup>+</sup> T-cells were labeled with eFluor670 and cultured alone, with bulk myeloid (m)DC or bulk monocytes (mono) at a ratio of 10:1. Following 24&#x000a0;h of culture, APC-T-cell co-cultures were infected with NL(AD8)&#x00394;nef-EGFP. <bold>b</bold> At day 5 post-infection productive infection was determined by quantification of EGFP in total cells and, non-proliferating, non-productively infected (eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup>) cells were sorted using flow cytometry and reactivated to determine frequency of latent infection. <bold>c</bold> Sorted non-proliferating (eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup>) CD4<sup>+</sup> T-cells were stimulated with phytohaemagglutinin (PHA) stimulated feeder PBMC for 5&#x000a0;days and EGFP quantified as a measure of HIV-1 latency. <italic>Columns</italic> represent the median of the log transformed values, <italic>open circles</italic> represent individual donors. *p&#x000a0;&#x02264;&#x000a0;0.05, **p&#x000a0;&#x02264;&#x000a0;0.005 as determined by paired students t-test</p></caption><graphic xlink:href="12977_2015_204_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec4"><title>Isolation of functional APC</title><p>Given that we were able to show induction of latency in non-proliferating CD4<sup>+</sup> T-cells following co-culture with both bulk monocytes and mDC, we next compared the latency inducing potential of the different monocyte and mDC subpopulations. Monocytes were sorted into CD14<sup>+</sup> and CD14<sup>lo</sup>CD16<sup>+</sup> (CD16<sup>+</sup>) cells and mDC were sorted into CD1c<sup>+</sup>, CD141<sup>+</sup> and SLAN<sup>+</sup> DC, B-cells and pDC were also isolated by sorting (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). The final purity for all sorted APC subpopulations was &#x0003e;90&#x000a0;%, as determined post-sort by expression of specific known surface markers for the various subpopulations [<xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref>]. The APC subpopulations were examined using brightfield microscopy after culture (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b, c). The mDC and monocyte subpopulations were characterized with the formation of both long and short dendritic processes (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b, c) Comparatively, pDC and B-cells had few processes or ruffles (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b, c; [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref>]).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Isolation of antigen presenting cells. <bold>a</bold> Peripheral blood mononuclear cells (PBMC) were elutriated into three fractions: small lymphocytes, large lymphocytes and a monocyte/DC fraction. Resting CD4<sup>+</sup> T-cells were isolated from the small lymphocyte fraction by negative selection using magnetic beads. Bulk B-cells were isolated from a mixture of the small and large lymphocyte fractions using positive magnetic bead selection for CD19. Bulk DC subpopulations were positively selected on the basis of expression of CD1c, CD141, SLAN and CD123 from the DC/monocyte fraction using magnetic bead selection. The positive &#x0201c;DC enriched&#x0201d; (DC) population was then sorted by flow cytometry into the four DC populations (purity &#x0003e;95&#x000a0;%). The negative &#x0201c;DC depleted&#x0201d; (mono) fraction was labeled with the monocyte markers CD14 and CD16, positively selected using magnetic beads and further sorted by flow cytometry into CD14<sup>+</sup> and CD14<sup>lo</sup>CD16<sup>hi</sup> subsets (purity &#x0003e;90&#x000a0;%). <bold>b</bold>, <bold>c</bold> Representative <italic>dot plots</italic> and brightfield images show the purity and morphology of the sorted APC subpopulations, respectively. The <italic>scale bars</italic> represent 20&#x000a0;&#x003bc;m, images were annotated using ImageJ software</p></caption><graphic xlink:href="12977_2015_204_Fig2_HTML" id="MO2"/></fig></p><p>APC function was tested in a syngeneic mixed leukocyte reaction (MLR) using the proliferation dye eFluor670 to measure proliferation of resting CD4<sup>+</sup> T-cells. In the absence of mitogen stimulation, the relative potency of the various APC to induce T-cell proliferation at a ratio of 1 APC:10 CD4<sup>+</sup> T-cells is shown (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a). CD1c<sup>+</sup> DC were the most potent at activating resting CD4<sup>+</sup> T-cells, while pDC and CD141<sup>+</sup> DC were least potent. The use of superantigen staphylococcal enterotoxin B (SEB) at low dose in the MLR had a modest effect on enhancing the capacity of APC to induce T-cell proliferation. T-cell proliferation following co-culture and SEB treatment was highest with CD1c<sup>+</sup> DC and lowest with B-cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b), confirming previous observations by others [<xref ref-type="bibr" rid="CR26">26</xref>]. B-cells had a similar stimulatory capacity with and without superantigen (1.0 and 1.3&#x000a0;% proliferated CD4<sup>+</sup> T-cells). Finally, there was a dose response of CD4<sup>+</sup> T-cell proliferation with decreasing APC:T-cell ratio (1:10&#x02013;1000). Together, these data confirm that all the APC subpopulations isolated remained functional in the co-cultures used for infection.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Resting CD4<sup>+</sup> T-cell stimulation following co-culture with antigen presenting cells. Resting CD4<sup>+</sup> T-cells were labeled with the proliferation dye eFluor670 and co-cultured with one of seven antigen presenting cell (APC) subpopulations, including B-cells; monocyte subpopulations-CD14<sup>hi</sup> and CD14<sup>lo</sup>CD16<sup>hi</sup>; DC subpopulations- plasmacytoid (p)DC and myeloid (m)DC subpopulations&#x02014;CD1c<sup>+</sup>, CD141<sup>+</sup> and SLAN<sup>+</sup>, at a ratio of log 1 (10:1), 2 (100:1) or 3 (1000:1) T-cells : APC. T-cell stimulation was measured by quantification of the percentage of eFluor670<sup>lo</sup> CD4<sup>+</sup> T-cells from APC-T-cell co-cultures following 5&#x000a0;days of culture in the <bold>a</bold> absence (syngeneic) or <bold>b</bold> presence of staphylococcal enterotoxin B (SEB). <bold>c</bold> eFluor670 labeled, resting CD4<sup>+</sup> T-cells were cultured alone, or with APC subpopulations at a ratio of 10:1 and infected with NL(AD8)&#x00394;nef-EGFP. At day 3 post-infection, CD4<sup>+</sup> eFluor670<sup>lo</sup> T-cells were measured. Columns represent the median, open circles represent individual donors, *p&#x000a0;&#x02264;&#x000a0;0.05, as determined by Wilcoxon matched pairs signed rank test</p></caption><graphic xlink:href="12977_2015_204_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec5"><title>T-cell stimulation by APC subpopulations in HIV-1 infected co-cultures</title><p>We then measured T-cell proliferation following co-culture with different APC subpopulations at 3&#x000a0;days following HIV-1 infection. The pattern of APC potency in induction of CD4<sup>+</sup> T-cell proliferation in the presence of HIV-1 was similar to uninfected, sygeneic, co-cultures (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c), where proliferation of CD4<sup>+</sup> T-cells was highest with CD1c<sup>+</sup> DC and lowest with pDC. These experiments demonstrate that HIV-1 infection did not independently alter APC or T-cell function with respect to T-cell proliferation.</p></sec><sec id="Sec6"><title>Several APC subpopulations enhanced productive infection of resting CD4<sup>+</sup> T-cells</title><p>We tested the ability of APC subpopulations to induce both productive and latent infection in resting CD4<sup>+</sup> T-cells when cultured alone or co-cultured with one of the seven sorted APC subpopulations (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). Five days following infection, EGFP expression was quantified by flow cytometry as a measure of productive infection (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). We observed a significant increase in productive infection following HIV-1 infection in all APC co-cultured with T-cells compared to resting CD4<sup>+</sup> T-cells cultured alone (p&#x000a0;=&#x000a0;0.03 for all APC co-cultures; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>b).<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Productive and latent infection in resting T-cells co-cultured with antigen presenting cell subsets. <bold>a</bold> Representative dot plot of CD4<sup>+</sup> T-cells co-cultured with antigen presenting cell (APC) subpopulations day 5 post infection with NL(AD8)&#x00394;nef-EGFP. Non-proliferating (eFluor670<sup>hi</sup>), non-productively infected (EGFP<sup>&#x02212;</sup>) T-cells were sorted 5&#x000a0;days following infection. <bold>b</bold> EGFP expression in the total cell cultures at day 5 post-infection was used as a measure of productive infection. <bold>c</bold> Total and post-integrated latency was stimulated from eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup> cells with anti-CD3/CD28 and IL-7 for 3&#x000a0;days and EGFP expression was quantified using flow cytometry. Representative <italic>dot plots</italic> show EGFP expression following stimulation of eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup> sorted CD4<sup>+</sup> T-cells in the absence (-L8 plot; total latency) and presence (+L8 plot; post integration latency) of the integrase inhibitor L8. <bold>d</bold> The frequency of total and <bold>e</bold> post-integration latent infection in resting CD4<sup>+</sup> T-cells following co-culture with APC subpopulations. <bold>f</bold> Correlation of the frequency of productive infection and post-integrated latency (+L8) in each APC-T-cell co-culture. Each condition is identified by a <italic>different color</italic> and/or <italic>symbol</italic>. For all other panels, columns represent the median and open circles represent results from individual donors. Significant differences between conditions was measured by Wilcoxon matched pairs signed rank test where *p&#x000a0;&#x02264;&#x000a0;0.05</p></caption><graphic xlink:href="12977_2015_204_Fig4_HTML" id="MO4"/></fig></p></sec><sec id="Sec7"><title>Different APC subpopulations can effectively induce latent infection in non-proliferating CD4<sup>+</sup> T-cells</title><p>Five days following infection, non-proliferating (eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup>) CD4<sup>+</sup> T-cells were sorted from the APC-T-cell co-cultures to quantify latent infection (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a). The sorted CD4<sup>+</sup> T-cells were directly stimulated with anti-CD3/CD28 and IL-7 (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c) in the presence and absence of an integrase inhibitor, L8. EGFP was quantified by flow cytometry as a measure of inducible latent infection. Total latent infection (no L8) was significantly increased in non-proliferating CD4<sup>+</sup> T-cells co-cultured with all mDC subpopulations, CD14<sup>+</sup> monocytes and B-cells, when compared to CD4<sup>+</sup> T-cells cultured alone (p&#x000a0;=&#x000a0;0.03; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d). In comparison, total latent infection following co-culture with CD14<sup>lo</sup>CD16<sup>+</sup> monocytes, that were depleted of SLAN<sup>+</sup> DC, was highly variable and not significantly different to T-cells cultured alone. As previously shown, latent infection was not found in T-cells co-cultured with pDC (p&#x000a0;=&#x000a0;0.03 compared to mDC co-cultures; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d).</p><p>We also quantified post-integration latent infection by stimulating T-cells with anti CD3/CD28 and IL-7 stimulation in the presence of L8. (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>c). The integrase inhibitor, L8, prevented any progression of pre-integration complexes to integration and inhibited secondary rounds of infection. Following infection of CD4<sup>+</sup> T-cells co-cultured with each APC subpopulation, post-integration latency followed a similar pattern to that observed for total latency, but at a lower frequency (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>d, e). Post-integration latency was significantly increased in CD4<sup>+</sup> T-cells following co-culture with mDC subpopulations CD1c<sup>+</sup> and SLAN<sup>+</sup>, and CD14<sup>+</sup> monocytes (p&#x000a0;=&#x000a0;0.03, 0.02 and 0.01, respectively; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>e). Post-integration latency induced by CD141<sup>+</sup> DC was elevated, similar to what was induced by other mDC subsets, but this did not reach statistical significance. In comparison, HIV-1 infection of T-cells co-cultured with SLAN DC depleted CD14<sup>&#x02212;</sup> CD16<sup>+</sup> monocytes, B-cells and pDC was similar to infection of CD4<sup>+</sup> T cells alone. Together these data show that only CD1c<sup>+</sup>mDC, SLAN<sup>+</sup> DC and CD14<sup>+</sup> monocytes were able to establish post-integration latent infection in non-proliferating CD4<sup>+</sup> T-cells, while B-cells and CD141<sup>+</sup> mDC were able to establish pre-integration latent infection. CD14<sup>lo</sup>CD16<sup>hi</sup> SLAN<sup>&#x02212;</sup> monocytes, like pDC, were unable to establish either pre or post-integration latency.</p><p>Next, we looked for a correlation between productive infection and post-integration latency following infection of T-cells co-cultured with different APC (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>f). Overall, we found a weak correlation between productive and latent infection (Spearman&#x02019;s r&#x000a0;=&#x000a0;0.12; p&#x000a0;=&#x000a0;0.02), which supports our previous findings [<xref ref-type="bibr" rid="CR14">14</xref>]. However, the induction of productive infection does not inevitably lead to post-integration latency in resting CD4<sup>+</sup> T-cells, as observed following co-culture with CD14<sup>lo</sup>CD16<sup>hi</sup> monocytes, B-cells and pDC. We conclude that cells able to establish both productive and latent infection likely share common functional characteristics, which favour the establishment and maintenance of latent infection.</p></sec><sec id="Sec8"><title>Differential gene expression of cell-surface expressed molecules on APC</title><p>We next used RNA-seq to compare gene expression for genes involved in T-cell interactions with APC subpopulations that induce latency (CD1c<sup>+</sup> DC, SLAN<sup>+</sup> DC and CD14<sup>+</sup> monocytes) compared to APC that could not (pDC). Due to difficulties isolating APC from T-cell co-cultures and HIV-1 infection, gene expression analysis was performed on freshly isolated APC subpopulations [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>]. Component analysis showed clustering of the SLAN DC and CD14 monocytes and separate clusters of pDC and mDC (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1). Given that we have previously shown that cell contact is important in mDC-induced latency [<xref ref-type="bibr" rid="CR14">14</xref>], we specifically selected genes encoding proteins that mediate mDC-T-cell interactions, including those in cell membrane compartments at the cell surface, and in intracellular vesicles such as endosomes and compartments giving rise to exosomes.</p><p>In APC subpopulations that induced post-integration HIV-1 latency compared to APC that didn&#x02019;t induce latency, we found 754 differentially upregulated genes (fold change &#x02265;2, p-value &#x0003c;0.01; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). Analysis for expression in cellular compartment (GeneCodis; <ext-link ext-link-type="uri" xlink:href="http://genecodis.cnb.csic.es">http://genecodis.cnb.csic.es</ext-link>), identified 285 known genes expressed in: membrane, plasma membrane, integral to membrane, integral to plasma membrane and cell junction ([<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR39">39</xref>]; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a). Of these, 53 protein-encoding genes that could establish cell contact with CD4<sup>+</sup> T-cells and potentially induce T-cell signaling were selected (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table&#x000a0;S1). Functionally these genes included; cellular adhesion (32 genes), antigen presentation (1 gene), T-cell activation (9 genes), immune checkpoints (5 genes), regulation of apoptosis (5 gene), and an unknown protein (1 genes). We further analysed the role of each gene in HIV-1 infection of DC and CD4<sup>+</sup> T-cells using a PubMed search for the interactions between DC and T-cells, and potential roles in the establishment of HIV-1 latency (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table&#x000a0;S1).<fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>Comparison of gene expression between latency inducing and non-inducing antigen presenting cell subpopulations using RNA-seq. <bold>a</bold> Gene expression profiles common to the latency inducing APC subpopulations (CD1c<sup>+</sup> mDC, SLAN<sup>+</sup> mDC and CD14<sup>+</sup> monocytes) compared with non-latency inducing APC (pDC) were selected (fold change &#x02265;2, p&#x000a0;&#x0003c;&#x000a0;0.01). Using GeneCodis, these 754 genes were categorised according to cellular compartment expression. <bold>b</bold> Encoded proteins expressed on APC surface and membrane compartments were further analysed for ability to signal to T-cells and involvement in HIV-1 infection. Representative heat map with &#x0003e;twofold differential gene expression of genes able to signal to T-cells, which are differentially expressed between latency inducing (CD1c<sup>+</sup> mDC, SLAN<sup>+</sup> mDC and CD14<sup>+</sup> monocytes) and non-inducing APC subpopulations (pDC)</p></caption><graphic xlink:href="12977_2015_204_Fig5_HTML" id="MO5"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Effects on HIV infection of genes differentially expressed by latency inducing and non-inducing antigen presenting cell subpopulations using RNA-seq</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Gene name</th><th align="left" rowspan="2">Gene symbol</th><th align="left" colspan="6">Function</th></tr><tr><th align="left">Antigen presentation</th><th align="left">Apoptosis regulation</th><th align="left">Cell proximity presentation</th><th align="left">Immune checkpoint blocker</th><th align="left">T-cell activation</th><th align="left">Unknown</th></tr></thead><tbody><tr><td align="left">Number of genes expressed in each category</td><td align="left"/><td char="." align="char">1</td><td char="." align="char">5</td><td char="." align="char">32</td><td char="." align="char">5</td><td char="." align="char">9</td><td char="." align="char">1</td></tr><tr><td align="left">
<italic>CD1d molecule</italic>
</td><td align="left">
<italic>CD1d</italic>
</td><td align="left">&#x02013;<sup>*,**</sup>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Lectin, galactoside-binding, soluble, 1</td><td align="left">LGALS1</td><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Vasoactive intestinal peptide receptor 1</td><td align="left">VIPR1</td><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">EF-hand domain family, member D2</td><td align="left">EFHD2</td><td align="left"/><td align="left">&#x02013;</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Tumor necrosis factor receptor superfamily, member 10a</td><td align="left">TNFRSF10A</td><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain</td><td align="left">TNFRSF10D</td><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Acid phosphatase, prostate</td><td align="left">ACPP</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">ADAM metallopeptidase domain 15</td><td align="left">ADAM15</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)</td><td align="left">CD18</td><td align="left"/><td align="left"/><td align="left">+<sup>*,**</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Carcinoembryonic antigen-related cell adhesion molecule 4</td><td align="left">CEACAM4</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">C-type lectin domain family 4, member G</td><td align="left">CLEC4G</td><td align="left"/><td align="left"/><td align="left">&#x02013;<sup>*,**</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">
<italic>C</italic>-<italic>type lectin domain family 7, member A</italic>
</td><td align="left">
<italic>CLEC7A</italic>
</td><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Cytotoxic and regulatory T cell molecule</td><td align="left">CRTAM</td><td align="left"/><td align="left"/><td align="left">&#x02013;<sup>**</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Colony stimulating factor 3 receptor (granulocyte)</td><td align="left">CSF3R</td><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Ephrin-B1</td><td align="left">EFNB1</td><td align="left"/><td align="left"/><td align="left">&#x02013;</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">
<italic>Endoglin</italic>
</td><td align="left">
<italic>END</italic>
</td><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Endothelial cell adhesion molecule</td><td align="left">ESAM</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">G protein-coupled receptor 133</td><td align="left">GPR133</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">
<italic>Intercellular adhesion molecule 3</italic>
</td><td align="left">
<italic>ICAM3</italic>
</td><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Leucine rich repeat containing 8 family, member C</td><td align="left">LRRC8C</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Multiple EGF-like-domains 9</td><td align="left">MEGF9</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Membrane protein, palmitoylated 7 (MAGUK p55 subfamily member 7)</td><td align="left">MPP7</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Macrophage scavenger receptor 1</td><td align="left">MSR1</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Osteoclast associated, immunoglobulin-like receptor</td><td align="left">OSCAR</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Plexin domain containing 2</td><td align="left">PLXDC2</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Syndecan 3</td><td align="left">SDC3</td><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">CD33 molecule</td><td align="left">CD33</td><td align="left"/><td align="left"/><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">Sphingosine-1-phosphate lyase 1</td><td align="left">SGPL1</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left">+</td><td align="left"/><td align="left"/></tr><tr><td align="left">
<italic>Sialic acid binding Ig</italic>-<italic>like lectin 10</italic>
</td><td align="left">
<italic>SIGLEC10</italic>
</td><td align="left"/><td align="left"/><td align="left">&#x02013;<sup>*</sup>
</td><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">Sialic acid binding Ig-like lectin 7</td><td align="left">SIGLEC7</td><td align="left"/><td align="left"/><td align="left">+<sup>**</sup>
</td><td align="left">+</td><td align="left"/><td align="left"/></tr><tr><td align="left">Sialic acid binding Ig-like lectin 9</td><td align="left">SIGLEC9</td><td align="left"/><td align="left"/><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">Synaptojanin 2 binding protein</td><td align="left">SYNJ2BP</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left">+</td><td align="left"/><td align="left"/></tr><tr><td align="left">T-cell lymphoma invasion and metastasis 1</td><td align="left">TIAM1</td><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left">+</td><td align="left"/><td align="left"/></tr><tr><td align="left">Transmembrane protein 2</td><td align="left">TMEM2</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left">+</td><td align="left"/><td align="left"/></tr><tr><td align="left">Tetraspanin 17</td><td align="left">TSPAN17</td><td align="left"/><td align="left"/><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">C-type lectin domain family 1, member A</td><td align="left">CLEC1A</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">Sialic acid binding Ig-like lectin 14</td><td align="left">SIGLEC14</td><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">CD101 molecule</td><td align="left">CD101</td><td align="left"/><td align="left"/><td align="left"/><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">CD52 molecule</td><td align="left">CD52</td><td align="left"/><td align="left">&#x02013;</td><td align="left"/><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">Hepatitis A virus cellular receptor 2</td><td align="left">HAVR2/Tim-3</td><td align="left"/><td align="left"/><td align="left"/><td align="left">&#x02013;<sup>**</sup>
</td><td align="left"/><td align="left"/></tr><tr><td align="left">Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6</td><td align="left">LILRA6</td><td align="left"/><td align="left"/><td align="left"/><td align="left">&#x02013;</td><td align="left"/><td align="left"/></tr><tr><td align="left">Poliovirus receptor</td><td align="left">PVR</td><td align="left"/><td align="left"/><td align="left"/><td align="left">+<sup>*</sup>
</td><td align="left"/><td align="left"/></tr><tr><td align="left">Neuropilin (NRP) and tolloid (TLL)-like 2</td><td align="left">NETO2</td><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/><td align="left"/></tr><tr><td align="left">CD48 molecule</td><td align="left">CD48</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0<sup>**</sup>
</td><td align="left"/></tr><tr><td align="left">Interleukin 15 receptor, alpha</td><td align="left">IL15RA</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">&#x02013;<sup>**</sup>
</td><td align="left"/></tr><tr><td align="left">Leucine rich repeat containing 25</td><td align="left">LRRC25</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">NFAT activating protein with ITAM motif 1</td><td align="left">NFAM1</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">Secreted and transmembrane 1</td><td align="left">SECTM1</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">V-set and immunoglobulin domain containing 2</td><td align="left">VSIG2</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">CD300e molecule</td><td align="left">CD300e</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td><td align="left"/></tr><tr><td align="left">CD83 molecule</td><td align="left">CD83</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0<sup>**</sup>
</td><td align="left"/></tr><tr><td align="left">CD86 molecule</td><td align="left">CD86</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char">0<sup>**</sup>
</td><td align="left"/></tr><tr><td align="left">Ecotropic viral integration site 2A</td><td align="left">EVI2A</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">+</td></tr></tbody></table><table-wrap-foot><p>The functional category shown were determined by the description from the DAVID (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/">http://david.abcc.ncifcrf.gov/</ext-link>) and GeneCards (<ext-link ext-link-type="uri" xlink:href="http://genecards.org/">http://genecards.org/</ext-link>) databases</p><p>+, increased latent infection; &#x02013;, inhibition of virus expression, 0, undefined. Genes that were common to the RNA-seq and microarray generated gene lists are in italics. *&#x000a0;represent a role in HIV infection of either DC (*) or T-cell (**). Data in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> is presented&#x000a0;with additional detail and references in Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary references</p></table-wrap-foot></table-wrap></p><p>We performed the same comparisons between selected APC subpopulations using our previously published microarray data [<xref ref-type="bibr" rid="CR40">40</xref>] and found 27 genes that could potentially induce T-cell signalling (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Figure S2; Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table&#x000a0;S2; [<xref ref-type="bibr" rid="CR40">40</xref>]). Five of these genes were common between microarray and RNAseq analyses, seven genes shared protein family and thirteen genes fell outside of significance (cut off of p&#x000a0;&#x0003c;&#x000a0;0.01), often with inconsistent replicates (n&#x000a0;=&#x000a0;3). The common genes included <italic>C</italic>-<italic>type lectin domain family 7 member A</italic> (<italic>CLEC</italic>-<italic>7A</italic>), <italic>endoglin, intracellular adhesion molecule 3</italic> (<italic>ICAM</italic>-<italic>3</italic>), <italic>sialic acid</italic>-<italic>binding immunoglobulin</italic>-<italic>type lectins</italic> (<italic>SIGLEC</italic>)-<italic>10</italic> and <italic>CD1d</italic>. CD1d is involved in lipid antigen presentation to T-cells, while the other 4 surface expressed proteins are involved in cellular adhesion [<xref ref-type="bibr" rid="CR41">41</xref>]. The common protein families included the SIGLEC family, CLEC family, leukocyte associated immunoglobulin like receptor (LILRA) family, G-Protein coupled receptor (GCPR) family and the tumor necrosis factor (TNF) receptor superfamily.</p></sec></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p>Latently infected cells are infrequent in HIV-1-infected patients on cART, and therefore robust in vitro models are needed to better understand the establishment and maintenance of latent infection. We have now shown that multiple APCs, in addition to mDC, are able to induce HIV-1 latency in non-proliferating CD4<sup>+</sup> T cells [<xref ref-type="bibr" rid="CR14">14</xref>]. Here, we have shown that the myeloid lineage cells capable of producing latent T-cell infection include subpopulations of blood derived mDC; CD1c<sup>+</sup>, SLAN<sup>+</sup> DC and CD14<sup>+</sup> monocytes, and confirmed that pDC are distinct in not generating latent infection. We have used RNA-seq analysis to define genes differentially expressed between APC subpopulations that could (CD1c<sup>+</sup>, SLAN<sup>+</sup>, CD14<sup>+</sup> monocytes) and could not induce latent infection (pDC), and identified genes mediating cell adhesion, T-cell activation, immune checkpoints (IC) and regulation of apoptosis as important pathways differentially upregulated in the APC that are able to induce latent infection.</p><p>Our results show that multiple blood derived mDC subsets can induce latent infection in non-proliferating CD4<sup>+</sup> T-cells, suggesting that this observation may extend to other DC and myeloid lineage cells, such as LC and dermal DC (DDC) though they may have different ontogeny [<xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. It is likely that mDC and monocyte lineage cells in lymphoid tissue, skin, mucosal surfaces, gastrointestinal tract (GIT) and sites of inflammation could allow seeding of CD4<sup>+</sup> T-cell viral reservoirs early following infection or during ART in tissue sites were cART penetration may not be optimal [<xref ref-type="bibr" rid="CR45">45</xref>].</p><p>We observed a trend between the ability of the different APCs to induce latent infection and efficient T-cell proliferation. This suggests that there may be a common mechanism for the induction of T-cell proliferation and induction of latent infection, even in non-proliferating cells, perhaps through a bystander mechanism. Efficient T-cell proliferation is favoured by the formation of an immunological synapse [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>] with cellular proximity [<xref ref-type="bibr" rid="CR48">48</xref>], major-histocompatibility complex (MHC)-T-cell receptor (TcR) interaction and co-stimulation [<xref ref-type="bibr" rid="CR49">49</xref>&#x02013;<xref ref-type="bibr" rid="CR52">52</xref>]. ICAM-1 interaction with leukocyte function-associated antigen (LFA)-1 can facilitate induction of latent infection in the DC-T-cell model [<xref ref-type="bibr" rid="CR14">14</xref>], while in other models of in vitro latency CD2 expression, a molecule that binds to LFA-3, was increased on latently infected cells [<xref ref-type="bibr" rid="CR53">53</xref>]. A large portion (60&#x000a0;%) of genes identified in the gene expression analysis mediates cellular proximity and cell adhesion. Taken together these data suggest that cell adhesion/contact is important in the induction of latency. However, identification of a single specific adhesion molecule critical for the induction of latent infection is likely limited by functional redundancy in mediators of APC-T-cells interactions.</p><p>Compared to the other DCs, the pDC were least efficient for T-cell proliferation and induced significantly less productive and latent infection compared to mDC. The differences between mDC and pDC in induction of productive infection [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>] and suppression of virus production has been observed previously [<xref ref-type="bibr" rid="CR14">14</xref>]. We have also previously shown that pDC were unable to induce HIV-1 latency, and that there was a more substantial suppressive effect on the establishment of latency compared to productive infection. We and others have shown multiple differences between mDC and pDC that may reduce the ability of pDC to establish close interactions with T-cells [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>], which in combination with increased type-I IFN secretion from pDC may inhibit the capacity of pDC to establish latency in T-cells.</p><p>The ability of B-cells to induce latent infection in non-proliferating CD4<sup>+</sup> T-cells was also tested in this study as B-cells express MHC-II, circulate through LN, and have been reported to transfer HIV-1 infection to T-cells [<xref ref-type="bibr" rid="CR58">58</xref>]. Induction of latency occurred only at low level and was only in the form of pre-integration latency suggesting that B-cells lack factors that facilitate efficient induction of post-integration latency.</p><p>Comparison of APC subpopulations that could and could not induce latent infection in non-proliferating CD4<sup>+</sup> T-cells identified several functions that may be important in the establishment of latency, including cell adhesion, IC, T-cell co-stimulation, antigen presentation and regulation of apoptosis. The IC, programmed death receptor (PD)-1, is proposed to play a role in the establishment and/or maintenance of HIV-1 latency [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. Engagement of ICs, led to reduced T-cell activation by inhibition of signaling cascades, as well as physical inhibition of the formation of lipid rafts and cellular interactions [<xref ref-type="bibr" rid="CR61">61</xref>]. In this study, we observed an up-regulation of the ICs; <italic>CD101, T</italic>-<italic>cell immunoglobulin mucin</italic>-<italic>3</italic> (<italic>Tim</italic>-<italic>3, HAVR2</italic>), <italic>leukocyte immunoglobulin</italic>-<italic>like receptor member 6</italic> (<italic>LILR6</italic>) and <italic>CD52</italic>, on latency inducing APC subpopulations when compared to pDC. IC expression may be important for the establishment of HIV-1 latency in this model, but further work is required to confirm this.</p><p>Additionally, we identified differential expression of the SIGLEC family of proteins between APC subpopulations that could and could not induce latent infection. We specifically found <italic>SIGLEC 5, 7, 9, 10</italic> and <italic>14</italic> to be upregulated on latency inducing APCs. From this family, SIGLEC 3, 5-11 have all been implicated in the inhibition of T-cell activation [<xref ref-type="bibr" rid="CR62">62</xref>&#x02013;<xref ref-type="bibr" rid="CR64">64</xref>]. SIGLEC 5 has been shown to inhibit T-cell activation in chimpanzees, where blockade of SIGLEC 5 led to increased T-cell activation, and transfection of SIGLEC 5 into SIGLEC negative cells reduced T-cell activation [<xref ref-type="bibr" rid="CR64">64</xref>&#x02013;<xref ref-type="bibr" rid="CR67">67</xref>]. SIGLEC 10 is hypothesized to have similar function in inhibition of T-cell activation [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. Together these data suggest that SIGLEC 5 or 10 binding to its ligand on the CD4<sup>+</sup> T-cell may reduce T-cell activation, reduce productive infection and potentially promote latent infection. This is a novel association but further work will be required to explore any direct effects of SIGLEC proteins and the establishment of latency.</p></sec><sec id="Sec10" sec-type="conclusions"><title>Conclusion</title><p>This study has established that multiple myeloid lineage APC subpopulations can facilitate latent infection in resting CD4<sup>+</sup> T-cells. Particularly important is the observation that CD14<sup>+</sup> monocytes can induce latent infection in resting CD4<sup>+</sup> T-cells. The use of CD14<sup>+</sup> monocytes will greatly enhance the utility of this model. In addition, through a comparative analysis of APC populations, we have identified new pathways that may potentially be involved in the establishment and/or maintenance of HIV-1 latency. Inhibition of key pathways involved in mDC-T-cell interactions and HIV-1 latency may provide novel targets to eliminate HIV-1 latency.</p></sec><sec id="Sec11" sec-type="methods"><title>Methods</title><sec id="Sec12"><title>Isolation and preparation of resting CD4<sup>+</sup> T-cells and B-cells</title><p>PBMC were isolated by Ficoll-Paque density gradient centrifugation (GE Healthcare, Chalfont St. Giles, UK) from healthy buffy coats obtained from the Australian Red Cross. PBMC were further separated into three populations by counter-current elutriation using Beckman J-6M/E centrifuge equipped with a JE 5.0 rotor (Beckman Coulter, Pasedena, CA, USA; [<xref ref-type="bibr" rid="CR70">70</xref>]). The three fractions were isolated at rates of 12 (small lymphocytes), 16 (large lymphocytes) and 20 (DC/Monocytes fractions) ml/min. Resting CD4<sup>+</sup> T-cells, negative for the activation markers CD69 and HLA-DR, were sorted from the &#x0201c;small lymphocyte&#x0201d; fraction, as previously described [<xref ref-type="bibr" rid="CR14">14</xref>], with a purity always &#x0003e;98&#x000a0;%. B-cells were isolated with a purity of &#x02265;90&#x000a0;% from the &#x0201c;small and large lymphocyte&#x0201d; fractions using positive magnetic bead selection on an autoMACS (Miltenyi) using anti-CD19<sup>+</sup> hybridoma (clone FMC63) and anti-IgG microbeads (Miltenyi, Bergisch Gladbach, Germany).</p></sec><sec id="Sec13"><title>Isolation of DC and monocytes</title><p>The remaining elutriated fraction, containing the larger cells (20&#x000a0;ml/min), was used to isolate DC and monocytes. The large cell fraction was first stained with antibodies specific for the DC subsets, which included CD1c-APC (Miltenyi), CD141-VioBlue (Miltenyi), CD123-PE (BD BioSciences, Franklin Lakes, NJ, USA) and SLAN-FITC (Miltenyi), and labeled with anti-IgG beads (Miltenyi). DC were then isolated using an AutoMACS (Miltenyi) into positive and negative fractions. The positive fraction (DC enriched) was further sorted into four DC subsets: CD1c<sup>+</sup> mDC, SLAN<sup>+</sup> DC, CD141<sup>+</sup> mDC and CD123<sup>+</sup> pDC, using a FACSAria (BD BioSciences). The negative fraction (DC depleted/mono) was stained with anti-CD14-FITC and anti-CD16-PE (BD Biosciences) antibodies, labeled with IgG beads (Miltenyi) and a positive selection performed using an AutoMACS (Miltenyi) to obtain a bulk monocyte population. These cells were further sorted to obtain the CD14<sup>+</sup>CD16<sup>&#x02212;</sup> (CD14<sup>+</sup>) and CD16<sup>+</sup>CD14<sup>lo</sup> (CD16<sup>+</sup>) monocyte subsets using a FACSAria. Cell populations with a purity &#x02265;90&#x000a0;% were used, as determined by flow cytometry (LSR II or FACSAria; BD Bioscience). In the event of low yields of some APC subpopulation, the experiment was continued without that population. In these experiments the missing data was omitted from the plots and therefore not every donor has data shown for all conditions tested.</p></sec><sec id="Sec14"><title>Imaging antigen presenting cell subpopulations</title><p>After isolation, each antigen presenting cell (APC) subpopulation was cultured in RF10 media (RPMI 1640; Life Technologies, Carlsbad, CA, USA), supplemented with 10&#x000a0;% fetal bovine serum (FBS; Interpath, Heidelberg, Australia), Penicillin&#x02013;Streptomycin-Glutamine (PSG; Life Technologies) for 1&#x02013;2&#x000a0;h at 37&#x000a0;&#x000b0;C in glass-bottom imaging plates (&#x003bc;-slide, ibidi, Martinsried, Germany). Ten representative images were captured on a CCD camera through a 10&#x000a0;&#x000d7;&#x000a0;0.3 NA lens on a Olympus IX51 microscope and annotated with ImageJ software.</p></sec><sec id="Sec15"><title>Syngeneic mixed leukocyte reactions</title><p>Resting CD4<sup>+</sup> T-cells were labeled with eFluor670 and co-cultured with decreasing concentrations of each APC subpopulation; log 1 (10:1), 2 (100:1) and 3 (1000:1), in the absence (syngeneic) or presence of superantigen SEB (10&#x000a0;ng/mL; Sigma). At day 5, cells were harvested and labeled with antibody against CD3 (V450, BD Bioscience). Cells were analysed by flow for T-cells that proliferated and therefore expressed low levels of eFluor670.</p></sec><sec id="Sec16"><title>Viral plasmids, virus preparation and infection</title><p>In all experiments, we used HIV-1 NL4.3 plasmid backbone with an AD8 envelope and EGFP inserted in the <italic>nef</italic> open reading frame at position 75 (NL(AD8)&#x00394;<italic>nef</italic>EGFP) [<xref ref-type="bibr" rid="CR14">14</xref>], kindly provided by Damian Purcell, University of Melbourne (Melbourne, Australia). Viral stocks were generated by FuGene (Promega, Madison, WI, USA) transfection of 293T cells as previously described [<xref ref-type="bibr" rid="CR14">14</xref>]. Cells were infected at an MOI of 0.5, as determined by limiting dilution in PHA-stimulated PBMC using the Reed and Muench method [<xref ref-type="bibr" rid="CR71">71</xref>].</p></sec><sec id="Sec17"><title>In vitro latency model</title><p>Resting CD4<sup>+</sup> T-cells were labeled with the proliferation dye eFluor670 and cultured alone or with one of seven sorted syngeneic APC subpopulations at a ratio of 10:1 for 24&#x000a0;h in IL-2 (2U/mL, Roche Diagnostics, Basel, Switzerland) supplemented RF10 media. APC included monocyte subpopulations (CD14<sup>+</sup>CD16<sup>&#x02212;</sup> and CD14<sup>lo</sup>CD16<sup>+</sup>), DC subpopulations (pDC, CD1c<sup>+</sup>, CD141<sup>+</sup> and SLAN<sup>+</sup>), and B-cells. Co-cultures were then infected with NL(AD8)&#x00394;<italic>nef</italic>EGFP for 2&#x000a0;h, after which time excess virus was washed away and cells were cultured for an additional 5&#x000a0;days. In order to compare APC stimulatory capacity between APC-T-cell co-cultures, at day 3 post-infection, cells were stained with anti-CD3-V450 (BD Biosciences) to differentiate between T-cell and APC, and the proportion of proliferated (eFluor670<sup>lo</sup>) CD4<sup>+</sup> T-cells were determined. Day 3 was used because this is when productive infection reached is maximum and remained high until day 5 (unpublished data). Additional APC-T-cell ratio&#x02019;s were not used due to low APC yields. At day 5 post-infection, productive infection was determined by EGFP expression and non-proliferating, non-productively infected (eFluor670<sup>hi</sup> EGFP<sup>&#x02212;</sup>) CD4<sup>+</sup> T-cells were sorted using a FACSAria.</p></sec><sec id="Sec18"><title>Reactivation of latency from resting T-cells</title><p>Latent infection in the sorted, non-proliferating CD4<sup>+</sup> T-cells (eFluor670<sup>hi</sup>EGFP<sup>&#x02212;</sup>) was determined by comparison of stimulated with un-stimulated T-cells sorted from APC-T-cell co-cultures (control). 1x10<sup>5</sup> sorted CD4<sup>+</sup> T-cells were stimulated with immobilized anti-CD3 (7&#x000a0;&#x003bc;g/ml; Beckman Coulter), in RF10 media supplemented with CD28 (5&#x000a0;&#x003bc;g/mL; BD Biosciences), IL-7 (50&#x000a0;ng/mL; Sigma, St Louis, MO, USA), IL-2 (5U/mL; Roche), with (post-integrated latency) or without (total latency: pre- and post-integrated latency) integrase inhibitor L8 (1&#x000a0;&#x003bc;M; Merck, White House Station, NJ, USA). The concentration of L8 was determined previously by titration of L8 in phytohaemagglutinin (PHA; 10&#x000a0;&#x003bc;g/mL) activated PBMC infected with R5-EGFP virus at an MOI of 0.5, same concentration usedin co-cultures, and showed productive infection was completely blocked at 1&#x000a0;&#x003bc;M. This concentration used for all subsequent experiments. Cells were harvested after 72&#x000a0;h of stimulation and EGFP expression was quantified on the FacsCalibur (BD BioSciences).</p><p>In some experiments PHA (10ug/mL) and IL-2 (10&#x000a0;U/mL) stimulated feeder PBMC were used to activate T-cells as a measure of inducing virus replication form latency, as described previously [<xref ref-type="bibr" rid="CR14">14</xref>].</p></sec><sec id="Sec19"><title>Cell preparation for next generation sequencing and generation of gene lists</title><p>APC from 3 donors were sorted as described above to obtain mDC subpopulations CD1c<sup>+</sup>, SLAN<sup>+</sup>, CD14<sup>+</sup> monocytes and pDC which were immediately stored in RLT buffer (Qiagen, Limburg, The Netherlands). Total RNA was isolated from low cell number samples (&#x0003c;500,000 cells) using Qiagen ALL prep micro kits (Qiagen), while RNA from samples with &#x0003e;500,000 cells were isolated using Qiagen RNA easy mini kits (Qiagen), according to the manufacturer&#x02019;s instructions. Total RNA content varied from 270.0 to 1879.7&#x000a0;ng.</p><p>The Australian Gene Research Facility Ltd (AGRF, Melbourne, Australia) prepared cDNA libraries, which were multiplexed on the Illumina HiSeq&#x000a0;2000 (Illumina, San Diago, CA, USA). For gene expression analysis, single reads were selected with 20 million reads of 50&#x000a0;bp read size gathered. The RNA-seq reads were aligned to the human reference hg19 using the TopHat2 aligner [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>] and quantified using htseq-count [<xref ref-type="bibr" rid="CR74">74</xref>]. Mapping rates for RNA seq are shown (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S3). Differential expression was calculated using Voom/Limma [<xref ref-type="bibr" rid="CR75">75</xref>] and visualization performed using Degust [<xref ref-type="bibr" rid="CR76">76</xref>] (<ext-link ext-link-type="uri" xlink:href="http://victorian-bioinformatics-consortium.github.io/degust/">http://victorian-bioinformatics-consortium.github.io/degust/</ext-link>) and Vennt [<xref ref-type="bibr" rid="CR77">77</xref>] (<ext-link ext-link-type="uri" xlink:href="http://drpowell.github.io/vennt/">http://drpowell.github.io/vennt/</ext-link>). Genes with fewer than 10 reads across every sample were removed from the analysis.</p><p>APC subsets were categorized as latency-inducing and latency-non-inducing subsets. Using a fold change of greater than 2 and false discovery rate (FDR) of 0.01, we identified 754 genes that were significantly upregulated in latency inducing populations (CD1c<sup>+</sup> mDC, CD14<sup>+</sup> monocytes, SLAN<sup>+</sup> DC) compared to latency non-inducing populations (pDC; Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). As direct cell contact is required for the establishment of mDC induced latency, only protein encoding genes from APC implicated in cell contact were selected using the GeneCodis database (<ext-link ext-link-type="uri" xlink:href="http://genecodis.cnb.csic.es">http://genecodis.cnb.csic.es</ext-link>). We identified 285 genes from the initial list that encode for proteins known to be expressed on the plasma-membrane, membrane, integral to the plasma-membrane/membrane and cell junctions [<xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR39">39</xref>]. Finally, we manually curated this list to identify 53 genes known to be involved in T-cell signaling (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). RNA-seq data is available through Gene Omnibus (GEO), serial number GSE70106.</p><p>As a comparison, we performed a similar analysis using our previously published microarray data using the same APC subpopulations [<xref ref-type="bibr" rid="CR40">40</xref>]. Microarray data was kindly provided by Andrew Harman, Westmead Millennium Institute for Medical Research, Sydney University, Sydney [<xref ref-type="bibr" rid="CR40">40</xref>]. The RNA extraction, labeling, hybridization, data processing, and analysis procedures used by Harman et al. are described previously for the cDNA gene array [<xref ref-type="bibr" rid="CR78">78</xref>] and Illumina arrays [<xref ref-type="bibr" rid="CR79">79</xref>]. Hybridization and data processing was performed by AGRF using sentrix human 6 v2 expression chips (Illumina).</p></sec><sec id="Sec20"><title>Ethics approval</title><p>The use of blood samples from normal donors for this study was approved by the Alfred Hospital (HREC 156/11) and Monash University (CF11/1888) Human Research and Ethics Committees. Donors were recruited by the Red Cross Blood Transfusion Service as normal blood donors and all provided written informed consent for the use of their blood products for the research.</p></sec><sec id="Sec21"><title>Statistical analysis</title><p>Differences between experimental conditions were analyzed using Wilcoxon matched pairs signed rank test (n&#x000a0;&#x02265;&#x000a0;5) or paired student T-test (n&#x000a0;&#x0003c;&#x000a0;5) on GraphPad Prism (Version 6). P-values &#x02264;0.05 were considered significant. Differentially expressed RNA-seq and microarray genes were found to be significant using ANOVA [<xref ref-type="bibr" rid="CR40">40</xref>].</p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec22"><title>Additional files</title><p><media position="anchor" xlink:href="12977_2015_204_MOESM1_ESM.pdf" id="MOESM1"><caption><p>
<ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/supplementary/s12977-015-0204-2-S1.pdf"><bold>Additional file 1: Figure&#x000a0;S1.</bold></ext-link> Multidimensional scaling (MDS) of sequenced APC subpopulations. RNA sequences were measured according to two dimensions, 1 (x-axis) and 2 (y-axis). Each dot represents an antigen presenting cell (APC) subpopulation sequence, as labeled, n&#x000a0;=&#x000a0;3. Clustering of dots is indicative of similar gene expression profiles.</p></caption></media><media position="anchor" xlink:href="12977_2015_204_MOESM2_ESM.csv" id="MOESM2"><caption><p>
<ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/supplementary/s12977-015-0204-2-S2.csv"><bold>Additional file 2: Table&#x000a0;S1.</bold></ext-link> Comparison of gene expression between latency inducing and non-inducing antigen presenting cell subpopulations using RNA-seq. Using the bioinformatics databases DAVID&#x000a0;[<xref ref-type="bibr" rid="CR80">80</xref>], GeneCards and GeneCodis, cell compartment gene function was determine of each gene. Genes expressed on antigen presenting cell (APC)-surface with the ability to signal to T-cells were shortlisted and their role in HIV-1 infection and DC-T-cell interaction was further determined using PubMed. Genes that were common to the RNA-seq and microarray generated gene lists are in <italic>italics</italic> and underlined&#x000a0;in Table <xref rid="Tab1" ref-type="table">1</xref>. Acronyms used: intracellular adhesion molecules (ICAM), C-type lectin (CLEC), immunoglobulin (Ig), T-cell immune-receptor with Ig and tyrosine-based inhibition motif (ITIM) domains (TIGIT), DNAX accessory molecule-1 (DNAM-1), cytotoxic and regulatory T-cell molecule (CRTAM), junction adhesion molecules (JAMs), blood brain barrier (BBB), leukocyte function antigen (LFA), dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), galectin-1 (Gal-1), cysteine-dependent aspartate-directed proteases (caspase), factor for adipocyte differentiation 158 (FAD158), extracellular matrix (ECM), lymph node (LN), nuclear factor-kappa-B (NFkB), vascular endothelial growth factor (VEGF), major histocompatibility complex (MHC), T-cell receptor (TcR), cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), TYRO protein tyrosine kinase-binding protein (TYROBP), interleukin (IL-), nuclear factor of activated T-cells (NFAT), vasoactive intestinal polypeptide receptor 1 (VIPR1), T-cell immunoglobulin mucin-3 (Tim-3), monocyte derived dendritic cells (MDDC), natural killer cells (NK), human T-lymphotropic virus (HTLV-1), NFAT activating protein with immune-receptor tyrosine-based activation motif (NFAM1, CNAIP), cortical thymocyte-like protein (CTH, CTXC), B-cell receptor (BcR), HIV-associated neurocognitive disorder (HAND), antibody dependent cellular cytotoxicity (ADCC), Fc receptor (FcR), scavenger receptor class-A-1 (SRA-1), epidermal growth factor like domain, multiple/protein 5/9 (EGFL5).</p></caption></media><media position="anchor" xlink:href="12977_2015_204_MOESM3_ESM.doc" id="MOESM3"><caption><p>
<ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/supplementary/s12977-015-0204-2-S3.doc"><bold>Additional file 3: Supplementary references to Table 1.</bold></ext-link> Included is the literature documenting the association of specific genes found in this study and changes in HIV infection and expression.</p></caption></media><media position="anchor" xlink:href="12977_2015_204_MOESM4_ESM.pdf" id="MOESM4"><caption><p>
<ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/supplementary/s12977-015-0204-2-S4.pdf"><bold>Additional file 4: Figure S2.</bold></ext-link> Differential gene expression assessed by microarray analysis between latency inducing and non-inducing antigen presenting cells. <bold>A</bold>. Microarray gene expression profiles of antigen presenting cell (APC) subpopulations that could induce latency (CD1c<sup>+</sup>, SLAN<sup>+</sup>, CD14<sup>+</sup> monocytes) in non-proliferating CD4<sup>+</sup> T-cells were compared with APC subpopulations that could not induce latency (plasmacytoid (p)DC). Genes that were expressed in all 3 latency inducing APC subpopulations, CD1c<sup>+</sup>, SLAN<sup>+</sup>, CD14<sup>+</sup> monocytes, were categorized as candidate 3, genes expressed in only 2 APC subpopulations were categorized as candidate 2 and genes expressed only in 1 APC subpopulation were categorized as candidate 1. <bold>B.</bold> Using the bioinformatics databases DAVID, GeneCards and GeneCodis, Candidate 2 and 3 gene lists were analyzed for cellular compartment and function. Genes expressed on the APC cell surface, with the ability to signal to T-cells were shortlisted. <bold>C.</bold> Heat map shows differentially expressed genes with&#x000a0;&#x02265;&#x000a0;twofold differences between latency inducing APC subpopulations (CD14<sup>+</sup> monocytes, CD1c<sup>+</sup> mDC and SLAN<sup>+</sup> mDC) and non-latency inducing (pDC).</p></caption></media><media position="anchor" xlink:href="12977_2015_204_MOESM5_ESM.csv" id="MOESM5"><caption><p>
<ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/supplementary/s12977-015-0204-2-S5.csv"><bold>Additional file 5: Table&#x000a0;S2.</bold></ext-link> Comparison of gene expression between latency inducing and non-inducing antigen presenting cell subpopulations using microarray. Using the bioinformatics databases DAVID, GeneCards and GeneCodis, gene expression compartment and function was determined. Genes expressed on the antigen presenting cell (APC)-surface with the ability to signal to T-cells were shortlisted.</p></caption></media><media position="anchor" xlink:href="12977_2015_204_MOESM6_ESM.csv" id="MOESM6"><caption><p>
<ext-link ext-link-type="uri" xlink:href="http://www.retrovirology.com/content/supplementary/s12977-015-0204-2-S6.csv"><bold>Additional file 6: Table&#x000a0;S3.</bold></ext-link> Sequence mapping rates in RNA-seq.</p></caption></media></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>APC</term><def><p>antigen presenting cell</p></def></def-item><def-item><term>cART</term><def><p>combination antiretroviral therapy</p></def></def-item><def-item><term>CLEC-7A</term><def><p>C-type lectin domain family 7 member A</p></def></def-item><def-item><term>DC</term><def><p>dendritic cells</p></def></def-item><def-item><term>DDC</term><def><p>dermal dendritic cell</p></def></def-item><def-item><term>EGFP</term><def><p>emerald-green fluorescent protein</p></def></def-item><def-item><term>FBS</term><def><p>fetal bovine serum</p></def></def-item><def-item><term>FDR</term><def><p>false discovery rate</p></def></def-item><def-item><term>FC</term><def><p>fold change</p></def></def-item><def-item><term>GCPR</term><def><p>G-coupled protein receptor</p></def></def-item><def-item><term>GEO</term><def><p>gene Omnibus</p></def></def-item><def-item><term>GIT</term><def><p>gastrointestinal tract</p></def></def-item><def-item><term>HAVR2</term><def><p>Hepatitis A virus cellular receptor 2</p></def></def-item><def-item><term>HIV-1</term><def><p>human immunodeficiency virus</p></def></def-item><def-item><term>ICAM</term><def><p>intracellular adhesion molecule 3</p></def></def-item><def-item><term>ICB</term><def><p>immune checkpoint blocker</p></def></def-item><def-item><term>IL-7</term><def><p>interluekin-7</p></def></def-item><def-item><term>IL-2</term><def><p>interluekin-2</p></def></def-item><def-item><term>LC</term><def><p>langerhan cell</p></def></def-item><def-item><term>LFA</term><def><p>leukocyte function associated antigen</p></def></def-item><def-item><term>LILR</term><def><p>leukocyte-associated immunoglobulin like receptor</p></def></def-item><def-item><term>LN</term><def><p>lymph node</p></def></def-item><def-item><term>mDC</term><def><p>myeloid dendritic cell</p></def></def-item><def-item><term>MHC</term><def><p>major histocompatibility complex</p></def></def-item><def-item><term>MLR</term><def><p>mixed leukocyte reaction</p></def></def-item><def-item><term>Mono</term><def><p>monocyte</p></def></def-item><def-item><term>PBMC</term><def><p>peripheral blood mononuclear cells</p></def></def-item><def-item><term>PD-1</term><def><p>programmed death receptor-1</p></def></def-item><def-item><term>pDC</term><def><p>plasmacytoid dendritic cell</p></def></def-item><def-item><term>PHA</term><def><p>phytohemagglutinin</p></def></def-item><def-item><term>SEB</term><def><p>staphylococcal enterotoxin B</p></def></def-item><def-item><term>SIGLEC</term><def><p>sialic acid-binding immunoglobulin-type lectins</p></def></def-item><def-item><term>SLAN</term><def><p>6-sulfo LacNAc</p></def></def-item><def-item><term>Tim-3</term><def><p>T-cell immunoglobulin mucin-3</p></def></def-item><def-item><term>TNF</term><def><p>tumor necrosis factor</p></def></def-item></def-list></glossary><ack><title>Authors&#x02019; contributions</title><p>NK carried out cell isolations and infection experiments with the assistance of KC. CdfP and JA assisted with imaging experiments NK performed RNA isolation. DRP performed most of the bioinformatics analysis for RNA-seq data and with NK generated and analysed genes lists. Microarray analysis was completed by PUC and NK. PUC, NK and SRL conceived the study, and participated in its design and coordination. Manuscript was prepared by PUC, NK, VE and JA. All authors read and approved the final manuscript.</p><sec id="d30e2921"><title>Acknowledgements</title><p>We thank Damian Purcell (University of Melbourne, Parkville, Australia) for providing us with the EGFP-reporter virus. We thank J. Le Masurier, M. Thomson, P. Donaldson and G. Paukovics (Alfred Medical Research and Educational Precinct (AMREP) Flow Cytometry Core Facility, Melbourne, Australia) for flow cytometric cell sorting. We thank the Australian Gene Research Facility Ltd (AGRF, Melbourne, Australia) for the guidance and support in processing of samples for RNA-seq. We thank A. Harman (Westmead Millennium Institute for Medical Research, Sydney University, Sydney, Australia) for access to microarray data, Jingling Zhou for assistance with elutriation protocol and Ajantha Solomon for assistance with RNA isolation techniques. We thank Renee van der Sluis for support in preparation of the manuscript.</p></sec><sec id="d30e2926"><title>Funding</title><p>NK is the recipient of the Australian Postgraduate Award (APA) (fund # Q05201 6609004). S.R.L is an NHMRC practitioner fellow. This work was supported by NHMRC project grant 1041795 and National Institutes of Health Delany AIDS Research Enterprise (DARE) to find a cure Collaboratory (U19 AI096109).</p></sec><sec id="d30e2931"><title>Compliance with ethical guidelines</title><p><bold>Competing interests</bold> The authors declare that they have no competing interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>TW</given-names></name><name><surname>Finzi</surname><given-names>D</given-names></name><name><surname>Margolick</surname><given-names>J</given-names></name><name><surname>Chadwick</surname><given-names>K</given-names></name><name><surname>Schwartz</surname><given-names>D</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><article-title>In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency</article-title><source>Nat Med</source><year>1995</year><volume>1</volume><fpage>1284</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1038/nm1295-1284</pub-id><?supplied-pmid 7489410?><pub-id pub-id-type="pmid">7489410</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finzi</surname><given-names>D</given-names></name><name><surname>Hermankova</surname><given-names>M</given-names></name><name><surname>Pierson</surname><given-names>T</given-names></name><name><surname>Carruth</surname><given-names>LM</given-names></name><name><surname>Buck</surname><given-names>C</given-names></name><name><surname>Chaisson</surname><given-names>RE</given-names></name><name><surname>Quinn</surname><given-names>TC</given-names></name><name><surname>Chadwick</surname><given-names>K</given-names></name><name><surname>Margolick</surname><given-names>J</given-names></name><name><surname>Brookmeyer</surname><given-names>R</given-names></name><name><surname>Gallant</surname><given-names>J</given-names></name><name><surname>Markowitz</surname><given-names>M</given-names></name><name><surname>Ho</surname><given-names>DD</given-names></name><name><surname>Richman</surname><given-names>DD</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><article-title>Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy</article-title><source>Science</source><year>1997</year><volume>278</volume><fpage>1295</fpage><lpage>1300</lpage><pub-id pub-id-type="doi">10.1126/science.278.5341.1295</pub-id><?supplied-pmid 9360927?><pub-id pub-id-type="pmid">9360927</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermankova</surname><given-names>M</given-names></name><name><surname>Siliciano</surname><given-names>JD</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Monie</surname><given-names>D</given-names></name><name><surname>Chadwick</surname><given-names>K</given-names></name><name><surname>Margolick</surname><given-names>JB</given-names></name><name><surname>Quinn</surname><given-names>TC</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><article-title>Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4<sup>+</sup> T lymphocytes in vivo</article-title><source>J Virol</source><year>2003</year><volume>77</volume><fpage>7383</fpage><lpage>7392</lpage><pub-id pub-id-type="doi">10.1128/JVI.77.13.7383-7392.2003</pub-id><?supplied-pmid 12805437?><pub-id pub-id-type="pmid">12805437</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>M</given-names></name><name><surname>Stanwick</surname><given-names>TL</given-names></name><name><surname>Dempsey</surname><given-names>MP</given-names></name><name><surname>Lamonica</surname><given-names>CA</given-names></name></person-group><article-title>HIV-1 replication is controlled at the level of T cell activation and proviral integration</article-title><source>EMBO J</source><year>1990</year><volume>9</volume><fpage>1551</fpage><lpage>1560</lpage><?supplied-pmid 2184033?><pub-id pub-id-type="pmid">2184033</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>JA</given-names></name><name><surname>Arrigo</surname><given-names>SJ</given-names></name><name><surname>Weitsman</surname><given-names>SR</given-names></name><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Haislip</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>IS</given-names></name></person-group><article-title>HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure</article-title><source>Cell</source><year>1990</year><volume>61</volume><fpage>213</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(90)90802-L</pub-id><?supplied-pmid 2331748?><pub-id pub-id-type="pmid">2331748</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>JA</given-names></name><name><surname>Haislip</surname><given-names>AM</given-names></name><name><surname>Krogstad</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>IS</given-names></name></person-group><article-title>Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle</article-title><source>J Virol</source><year>1992</year><volume>66</volume><fpage>1717</fpage><lpage>1725</lpage><?supplied-pmid 1371173?><pub-id pub-id-type="pmid">1371173</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosque</surname><given-names>A</given-names></name><name><surname>Planelles</surname><given-names>V</given-names></name></person-group><article-title>Induction of HIV-1 latency and reactivation in primary memory CD4<sup>+</sup> T cells</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>58</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-07-168393</pub-id><?supplied-pmid 18849485?><pub-id pub-id-type="pmid">18849485</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marini</surname><given-names>A</given-names></name><name><surname>Harper</surname><given-names>JM</given-names></name><name><surname>Romerio</surname><given-names>F</given-names></name></person-group><article-title>An in vitro system to model the establishment and reactivation of HIV-1 latency</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>7713</fpage><lpage>7720</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.11.7713</pub-id><?supplied-pmid 19017960?><pub-id pub-id-type="pmid">19017960</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>GK</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Braciale</surname><given-names>V</given-names></name><name><surname>Baron</surname><given-names>S</given-names></name><name><surname>Cloyd</surname><given-names>MW</given-names></name></person-group><article-title>A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4<sup>+</sup> T-lymphocytes</article-title><source>Virology</source><year>2006</year><volume>355</volume><fpage>127</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.07.020</pub-id><?supplied-pmid 16919704?><pub-id pub-id-type="pmid">16919704</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>H-C</given-names></name><name><surname>Xing</surname><given-names>S</given-names></name><name><surname>Shan</surname><given-names>L</given-names></name><name><surname>O&#x02019;Connell</surname><given-names>K</given-names></name><name><surname>Dinoso</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Shrum</surname><given-names>CK</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>JO</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Margolick</surname><given-names>JB</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><article-title>Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation</article-title><source>J Clin Invest</source><year>2009</year><volume>119</volume><fpage>3473</fpage><lpage>3486</lpage><?supplied-pmid 19805909?><pub-id pub-id-type="pmid">19805909</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pace</surname><given-names>MJ</given-names></name><name><surname>Graf</surname><given-names>EH</given-names></name><name><surname>Agosto</surname><given-names>LM</given-names></name><name><surname>Mexas</surname><given-names>AM</given-names></name><name><surname>Male</surname><given-names>F</given-names></name><name><surname>Brady</surname><given-names>T</given-names></name><name><surname>Bushman</surname><given-names>FD</given-names></name><name><surname>O&#x02019;Doherty</surname><given-names>U</given-names></name></person-group><article-title>Directly infected resting CD4<sup>+</sup> T cells can produce HIV gag without spreading infection in a model of HIV latency</article-title><source>PLoS Pathog</source><year>2012</year><volume>8</volume><fpage>e1002818</fpage><lpage>e1002833</lpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1002818</pub-id><?supplied-pmid 22911005?><pub-id pub-id-type="pmid">22911005</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiggard</surname><given-names>WJ</given-names></name><name><surname>Baytop</surname><given-names>C</given-names></name><name><surname>Yu</surname><given-names>JJ</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Schretzenmair</surname><given-names>R</given-names></name><name><surname>Theodosopoulos</surname><given-names>T</given-names></name><name><surname>O&#x02019;Doherty</surname><given-names>U</given-names></name></person-group><article-title>Human immunodeficiency virus type 1 can establish latent infection in resting CD4<sup>+</sup> T cells in the absence of activating stimuli</article-title><source>J Virol</source><year>2005</year><volume>79</volume><fpage>14179</fpage><lpage>14188</lpage><pub-id pub-id-type="doi">10.1128/JVI.79.22.14179-14188.2005</pub-id><?supplied-pmid 16254353?><pub-id pub-id-type="pmid">16254353</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>S</given-names></name><name><surname>Solomon</surname><given-names>A</given-names></name><name><surname>Wightman</surname><given-names>F</given-names></name><name><surname>Xhilaga</surname><given-names>M</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Lewin</surname><given-names>SR</given-names></name></person-group><article-title>CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4<sup>+</sup> T cells to HIV-1 infection: a novel model of HIV-1 latency</article-title><source>Blood</source><year>2007</year><volume>110</volume><fpage>4161</fpage><lpage>4164</lpage><pub-id pub-id-type="doi">10.1182/blood-2007-06-097907</pub-id><?supplied-pmid 17881634?><pub-id pub-id-type="pmid">17881634</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>VA</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Filali</surname><given-names>A</given-names></name><name><surname>Procopio</surname><given-names>FA</given-names></name><name><surname>Yegorov</surname><given-names>O</given-names></name><name><surname>Goulet</surname><given-names>J-P</given-names></name><name><surname>Saleh</surname><given-names>S</given-names></name><name><surname>Haddad</surname><given-names>EK</given-names></name><name><surname>da Fonseca Pereira</surname><given-names>C</given-names></name><name><surname>Ellenberg</surname><given-names>PC</given-names></name><name><surname>Sekaly</surname><given-names>RP</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Lewin</surname><given-names>SR</given-names></name></person-group><article-title>Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4<sup>+</sup> T Cells</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003799</fpage><lpage>e1003813</lpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1003799</pub-id><?supplied-pmid 24339779?><pub-id pub-id-type="pmid">24339779</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>A</given-names></name><name><surname>Baker</surname><given-names>JJ</given-names></name><name><surname>Scott</surname><given-names>GL</given-names></name><name><surname>Davis</surname><given-names>YP</given-names></name><name><surname>Ho</surname><given-names>Y-Y</given-names></name><name><surname>Siliciano</surname><given-names>RF</given-names></name></person-group><article-title>Endothelial cell stimulation overcomes restriction and promotes productive and latent HIV-1 infection of resting CD4<sup>+</sup> T Cells</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>9768</fpage><lpage>9779</lpage><pub-id pub-id-type="doi">10.1128/JVI.01478-13</pub-id><?supplied-pmid 23824795?><pub-id pub-id-type="pmid">23824795</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hladik</surname><given-names>F</given-names></name><name><surname>Sakchalathorn</surname><given-names>P</given-names></name><name><surname>Ballweber</surname><given-names>L</given-names></name><name><surname>Lentz</surname><given-names>G</given-names></name><name><surname>Fialkow</surname><given-names>M</given-names></name><name><surname>Eschenbach</surname><given-names>D</given-names></name><name><surname>McElrath</surname><given-names>MJ</given-names></name></person-group><article-title>Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1</article-title><source>Immunity</source><year>2007</year><volume>26</volume><fpage>257</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.01.007</pub-id><?supplied-pmid 17306567?><pub-id pub-id-type="pmid">17306567</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>LA</given-names></name><name><surname>Lehner</surname><given-names>T</given-names></name></person-group><article-title>Comparative investigation of Langerhans&#x02019; cells and potential receptors for HIV in oral, genitourinary and rectal epithelia</article-title><source>Immunology</source><year>1995</year><volume>85</volume><fpage>475</fpage><lpage>484</lpage><?supplied-pmid 7558138?><pub-id pub-id-type="pmid">7558138</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaitseva</surname><given-names>M</given-names></name><name><surname>Blauvelt</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lapham</surname><given-names>CK</given-names></name><name><surname>Kiaus-Kovrun</surname><given-names>V</given-names></name><name><surname>Mostowski</surname><given-names>H</given-names></name><name><surname>Manischewitz</surname><given-names>J</given-names></name><name><surname>Golding</surname><given-names>H</given-names></name></person-group><article-title>Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection</article-title><source>Nat Med</source><year>1997</year><volume>3</volume><fpage>1369</fpage><lpage>1375</lpage><pub-id pub-id-type="doi">10.1038/nm1297-1369</pub-id><?supplied-pmid 9396607?><pub-id pub-id-type="pmid">9396607</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerovic</surname><given-names>V</given-names></name><name><surname>Houston</surname><given-names>SA</given-names></name><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Aumeunier</surname><given-names>A</given-names></name><name><surname>Yrlid</surname><given-names>U</given-names></name><name><surname>Mowat</surname><given-names>AM</given-names></name><name><surname>Milling</surname><given-names>SWF</given-names></name></person-group><article-title>Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells</article-title><source>Mucosal Immunol.</source><year>2012</year><volume>6</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/mi.2012.53</pub-id><?supplied-pmid 22718260?><pub-id pub-id-type="pmid">22718260</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>C-C</given-names></name><name><surname>Ali</surname><given-names>N</given-names></name><name><surname>Karagiannis</surname><given-names>P</given-names></name><name><surname>Di Meglio</surname><given-names>P</given-names></name><name><surname>Skowera</surname><given-names>A</given-names></name><name><surname>Napolitano</surname><given-names>L</given-names></name><name><surname>Barinaga</surname><given-names>G</given-names></name><name><surname>Grys</surname><given-names>K</given-names></name><name><surname>Sharif-Paghaleh</surname><given-names>E</given-names></name><name><surname>Karagiannis</surname><given-names>SN</given-names></name><name><surname>Peakman</surname><given-names>M</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name><name><surname>Nestle</surname><given-names>FO</given-names></name></person-group><article-title>Resident CD141 (BDCA3)&#x000a0;+&#x000a0;dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation</article-title><source>J Exp Med</source><year>2012</year><volume>209</volume><fpage>935</fpage><lpage>945</lpage><pub-id pub-id-type="doi">10.1084/jem.20112583</pub-id><?supplied-pmid 22547651?><pub-id pub-id-type="pmid">22547651</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Bogunovic</surname><given-names>M</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>D</given-names></name><name><surname>Price</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>N</given-names></name><name><surname>Bromberg</surname><given-names>J</given-names></name><name><surname>Lira</surname><given-names>SA</given-names></name><name><surname>Stanley</surname><given-names>ER</given-names></name><name><surname>Nussenzweig</surname><given-names>M</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name></person-group><article-title>The origin and development of nonlymphoid tissue CD103&#x000a0;+&#x000a0;DCs</article-title><source>J Exp Med</source><year>2009</year><volume>206</volume><fpage>3115</fpage><lpage>3130</lpage><pub-id pub-id-type="doi">10.1084/jem.20091756</pub-id><?supplied-pmid 20008528?><pub-id pub-id-type="pmid">20008528</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>CI</given-names></name><name><surname>Becker</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Marches</surname><given-names>F</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Leboeuf</surname><given-names>M</given-names></name><name><surname>Anguiano</surname><given-names>E</given-names></name><name><surname>Pourpe</surname><given-names>S</given-names></name><name><surname>Goller</surname><given-names>K</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Palucka</surname><given-names>K</given-names></name></person-group><article-title>Human CD1c(+) dendritic cells drive the Differentiation of CD103(+) CD8(+) mucosal effector T cells via the cytokine TGF-&#x003b2;</article-title><source>Immunity</source><year>2013</year><volume>38</volume><fpage>818</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.004</pub-id><?supplied-pmid 23562160?><pub-id pub-id-type="pmid">23562160</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">H&#x000e4;nsel A, G&#x000fc;nther C, Baran W, Bidier M, Lorenz HM, Schmitz M, Bachmann M, D&#x000f6;bel T, Enk AH, Sch&#x000e4;kel K: Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus. J Autoimmun. 2012.</mixed-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>C</given-names></name><name><surname>Edwards</surname><given-names>EW</given-names></name><name><surname>Tacke</surname><given-names>F</given-names></name><name><surname>Angeli</surname><given-names>V</given-names></name><name><surname>Llodr&#x000e1;</surname><given-names>J</given-names></name><name><surname>Sanchez-Schmitz</surname><given-names>G</given-names></name><name><surname>Garin</surname><given-names>A</given-names></name><name><surname>Haque</surname><given-names>NS</given-names></name><name><surname>Peters</surname><given-names>W</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><name><surname>Sanchez-Torres</surname><given-names>C</given-names></name><name><surname>Bromberg</surname><given-names>J</given-names></name><name><surname>Charo</surname><given-names>IF</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Lira</surname><given-names>SA</given-names></name><name><surname>Randolph</surname><given-names>GJ</given-names></name></person-group><article-title>Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1231</fpage><lpage>1241</lpage><pub-id pub-id-type="doi">10.1084/jem.20032152</pub-id><?supplied-pmid 15534368?><pub-id pub-id-type="pmid">15534368</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group><article-title>Monocytes and macrophages: developmental pathways and tissue homeostasis</article-title><source>Nat Rev Immunol</source><year>2014</year><volume>14</volume><fpage>392</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1038/nri3671</pub-id><?supplied-pmid 24854589?><pub-id pub-id-type="pmid">24854589</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>KPA</given-names></name><name><surname>Munster</surname><given-names>DJ</given-names></name><name><surname>Clark</surname><given-names>GJ</given-names></name><name><surname>Dzionek</surname><given-names>A</given-names></name><name><surname>Schmitz</surname><given-names>J</given-names></name><name><surname>Hart</surname><given-names>DNJ</given-names></name></person-group><article-title>Characterization of human blood dendritic cell subsets</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>4512</fpage><lpage>4520</lpage><pub-id pub-id-type="doi">10.1182/blood-2001-11-0097</pub-id><?supplied-pmid 12393628?><pub-id pub-id-type="pmid">12393628</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>T</given-names></name></person-group><article-title>Microenvironmental niches in the bone marrow required for B-cell development</article-title><source>Nat Rev Immunol</source><year>2006</year><volume>6</volume><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1038/nri1780</pub-id><?supplied-pmid 16491135?><pub-id pub-id-type="pmid">16491135</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rissoan</surname><given-names>M-C</given-names></name><name><surname>Duhen</surname><given-names>T</given-names></name><name><surname>Bridon</surname><given-names>J-M</given-names></name><name><surname>Bendriss-Vermare</surname><given-names>N</given-names></name><name><surname>P&#x000e9;ronne</surname><given-names>C</given-names></name><name><surname>Vis B de</surname><given-names>S</given-names></name><name><surname>Bri&#x000e8;re</surname><given-names>F</given-names></name><name><surname>Bates</surname><given-names>EEM</given-names></name></person-group><article-title>Subtractive hybridization reveals the expression of immunoglobulinlike transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>3295</fpage><lpage>3303</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-02-0638</pub-id><?supplied-pmid 12384430?><pub-id pub-id-type="pmid">12384430</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000e4;kel</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>E</given-names></name><name><surname>Federle</surname><given-names>C</given-names></name><name><surname>Schmitz</surname><given-names>M</given-names></name><name><surname>Riethm&#x000fc;ller</surname><given-names>G</given-names></name><name><surname>Rieber</surname><given-names>EP</given-names></name></person-group><article-title>A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes</article-title><source>Eur J Immunol</source><year>1998</year><volume>28</volume><fpage>4084</fpage><lpage>4093</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-4141(199812)28:12&#x0003c;4084::AID-IMMU4084&#x0003e;3.0.CO;2-4</pub-id><?supplied-pmid 9862344?><pub-id pub-id-type="pmid">9862344</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziegler-Heitbrock</surname><given-names>L</given-names></name><name><surname>Ancuta</surname><given-names>P</given-names></name><name><surname>Crowe</surname><given-names>S</given-names></name><name><surname>Dalod</surname><given-names>M</given-names></name><name><surname>Grau</surname><given-names>V</given-names></name><name><surname>Hart</surname><given-names>DN</given-names></name><name><surname>Leenen</surname><given-names>PJM</given-names></name><name><surname>Liu</surname><given-names>Y-J</given-names></name><name><surname>MacPherson</surname><given-names>G</given-names></name><name><surname>Randolph</surname><given-names>GJ</given-names></name><name><surname>Scherberich</surname><given-names>J</given-names></name><name><surname>Schmitz</surname><given-names>J</given-names></name><name><surname>Shortman</surname><given-names>K</given-names></name><name><surname>Sozzani</surname><given-names>S</given-names></name><name><surname>Strobl</surname><given-names>H</given-names></name><name><surname>Zembala</surname><given-names>M</given-names></name><name><surname>Austyn</surname><given-names>JM</given-names></name><name><surname>Lutz</surname><given-names>MB</given-names></name></person-group><article-title>Nomenclature of monocytes and dendritic cells in</article-title><source>Blood</source><year>2010</year><volume>116</volume><fpage>e74</fpage><lpage>e80</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-02-258558</pub-id><?supplied-pmid 20628149?><pub-id pub-id-type="pmid">20628149</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissmann</surname><given-names>F</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group><article-title>Blood monocytes consist of two principal subsets with distinct migratory properties</article-title><source>Immunity</source><year>2003</year><volume>19</volume><fpage>71</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1016/S1074-7613(03)00174-2</pub-id><?supplied-pmid 12871640?><pub-id pub-id-type="pmid">12871640</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Doherty</surname><given-names>U</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name><name><surname>Gezelter</surname><given-names>S</given-names></name><name><surname>Kopeloff</surname><given-names>I</given-names></name><name><surname>Swiggard</surname><given-names>WJ</given-names></name><name><surname>Pope</surname><given-names>M</given-names></name><name><surname>Bhardwaj</surname><given-names>N</given-names></name></person-group><article-title>Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium</article-title><source>J Exp Med</source><year>1993</year><volume>178</volume><fpage>1067</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1084/jem.178.3.1067</pub-id><?supplied-pmid 8102389?><pub-id pub-id-type="pmid">8102389</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinman</surname><given-names>RM</given-names></name><name><surname>Cohn</surname><given-names>ZA</given-names></name></person-group><article-title>Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution</article-title><source>J Exp Med</source><year>1973</year><volume>137</volume><fpage>1142</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1084/jem.137.5.1142</pub-id><?supplied-pmid 4573839?><pub-id pub-id-type="pmid">4573839</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahn</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Jeon</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>S-J</given-names></name><name><surname>Lee</surname><given-names>B-H</given-names></name><name><surname>Choi</surname><given-names>KD</given-names></name><name><surname>Bae</surname><given-names>Y-S</given-names></name></person-group><article-title>Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>1742</fpage><lpage>1754</lpage><?supplied-pmid 12176896?><pub-id pub-id-type="pmid">12176896</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Majewski</surname><given-names>P</given-names></name><name><surname>Schulte</surname><given-names>LC</given-names></name><name><surname>Korn</surname><given-names>JM</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Hacohen</surname><given-names>N</given-names></name></person-group><article-title>The plasticity of dendritic cell responses to pathogens and their components</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>870</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1126/science.294.5543.870</pub-id><?supplied-pmid 11679675?><pub-id pub-id-type="pmid">11679675</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdijk</surname><given-names>P</given-names></name><name><surname>van Veelen</surname><given-names>PA</given-names></name><name><surname>de Ru</surname><given-names>AH</given-names></name><name><surname>Hensbergen</surname><given-names>PJ</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Koerten</surname><given-names>HK</given-names></name><name><surname>Koning</surname><given-names>F</given-names></name><name><surname>Tensen</surname><given-names>CP</given-names></name><name><surname>Mommaas</surname><given-names>AM</given-names></name></person-group><article-title>Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane</article-title><source>Eur J Immunol</source><year>2004</year><volume>34</volume><fpage>156</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1002/eji.200324241</pub-id><?supplied-pmid 14971041?><pub-id pub-id-type="pmid">14971041</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carmona-Saez</surname><given-names>P</given-names></name><name><surname>Chagoyen</surname><given-names>M</given-names></name><name><surname>Tirado</surname><given-names>F</given-names></name><name><surname>Carazo</surname><given-names>JM</given-names></name><name><surname>Pascual-Montano</surname><given-names>A</given-names></name></person-group><article-title>GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists</article-title><source>Genome Biol</source><year>2007</year><volume>8</volume><fpage>R3</fpage><pub-id pub-id-type="doi">10.1186/gb-2007-8-1-r3</pub-id><?supplied-pmid 17204154?><pub-id pub-id-type="pmid">17204154</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogales-Cadenas</surname><given-names>R</given-names></name><name><surname>Carmona-Saez</surname><given-names>P</given-names></name><name><surname>Vazquez</surname><given-names>M</given-names></name><name><surname>Vicente</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Tirado</surname><given-names>F</given-names></name><name><surname>Carazo</surname><given-names>JM</given-names></name><name><surname>Pascual-Montano</surname><given-names>A</given-names></name></person-group><article-title>GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information</article-title><source>Nucleic Acids Res</source><year>2009</year><volume>37</volume><issue>Web Server issue</issue><fpage>W317</fpage><lpage>W322</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp416</pub-id><?supplied-pmid 19465387?><pub-id pub-id-type="pmid">19465387</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabas-Madrid</surname><given-names>D</given-names></name><name><surname>Nogales-Cadenas</surname><given-names>R</given-names></name><name><surname>Pascual-Montano</surname><given-names>A</given-names></name></person-group><article-title>GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics</article-title><source>Nucleic Acids Res</source><year>2012</year><volume>4</volume><issue>Web Server issue</issue><fpage>W478</fpage><lpage>W483</lpage><pub-id pub-id-type="doi">10.1093/nar/gks402</pub-id><pub-id pub-id-type="pmid">22573175</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>AN</given-names></name><name><surname>Bye</surname><given-names>CR</given-names></name><name><surname>Nasr</surname><given-names>N</given-names></name><name><surname>Sandgren</surname><given-names>KJ</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Mercier</surname><given-names>SK</given-names></name><name><surname>Botting</surname><given-names>RA</given-names></name><name><surname>Lewin</surname><given-names>SR</given-names></name><name><surname>Cunningham</surname><given-names>AL</given-names></name><name><surname>Cameron</surname><given-names>PU</given-names></name></person-group><article-title>Identification of lineage relationships and novel markers of blood and skin human dendritic cells</article-title><source>J Immunol Baltim Md</source><year>1950</year><volume>2013</volume><issue>190</issue><fpage>66</fpage><lpage>79</lpage></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>H</given-names></name><name><surname>Mandraju</surname><given-names>R</given-names></name><name><surname>Coelho-dos-Reis</surname><given-names>JGA</given-names></name><name><surname>Tsuji</surname><given-names>M</given-names></name></person-group><article-title>Effects of HIV-1-induced CD1c and CD1d modulation and endogenous lipid presentation on CD1c-restricted T-cell activation</article-title><source>BMC Immunol</source><year>2013</year><volume>14</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/1471-2172-14-4</pub-id><pub-id pub-id-type="pmid">23286717</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haniffa</surname><given-names>M</given-names></name><name><surname>Shin</surname><given-names>A</given-names></name><name><surname>Bigley</surname><given-names>V</given-names></name><name><surname>McGovern</surname><given-names>N</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><name><surname>See</surname><given-names>P</given-names></name><name><surname>Wasan</surname><given-names>PS</given-names></name><name><surname>Wang</surname><given-names>X-N</given-names></name><name><surname>Malinarich</surname><given-names>F</given-names></name><name><surname>Malleret</surname><given-names>B</given-names></name><name><surname>Larbi</surname><given-names>A</given-names></name><name><surname>Tan</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Poidinger</surname><given-names>M</given-names></name><name><surname>Pagan</surname><given-names>S</given-names></name><name><surname>Cookson</surname><given-names>S</given-names></name><name><surname>Dickinson</surname><given-names>R</given-names></name><name><surname>Dimmick</surname><given-names>I</given-names></name><name><surname>Jarrett</surname><given-names>RF</given-names></name><name><surname>Renia</surname><given-names>L</given-names></name><name><surname>Tam</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Connolly</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>JKY</given-names></name><name><surname>Gehring</surname><given-names>A</given-names></name><name><surname>Bertoletti</surname><given-names>A</given-names></name><name><surname>Collin</surname><given-names>M</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name></person-group><article-title>Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells</article-title><source>Immunity</source><year>2012</year><volume>37</volume><fpage>60</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.04.012</pub-id><?supplied-pmid 22795876?><pub-id pub-id-type="pmid">22795876</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGovern</surname><given-names>N</given-names></name><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>Gunawan</surname><given-names>M</given-names></name><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Shin</surname><given-names>A</given-names></name><name><surname>Poyner</surname><given-names>E</given-names></name><name><surname>Green</surname><given-names>K</given-names></name><name><surname>Dickinson</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X-N</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><name><surname>Best</surname><given-names>K</given-names></name><name><surname>Covins</surname><given-names>S</given-names></name><name><surname>Milne</surname><given-names>P</given-names></name><name><surname>Pagan</surname><given-names>S</given-names></name><name><surname>Aljefri</surname><given-names>K</given-names></name><name><surname>Windebank</surname><given-names>M</given-names></name><name><surname>Saavedra</surname><given-names>DM</given-names></name><name><surname>Larbi</surname><given-names>A</given-names></name><name><surname>Wasan</surname><given-names>PS</given-names></name><name><surname>Duan</surname><given-names>K</given-names></name><name><surname>Poidinger</surname><given-names>M</given-names></name><name><surname>Bigley</surname><given-names>V</given-names></name><name><surname>Ginhoux</surname><given-names>F</given-names></name><name><surname>Collin</surname><given-names>M</given-names></name><name><surname>Haniffa</surname><given-names>M</given-names></name></person-group><article-title>Human dermal CD14<sup>+</sup> cells are a transient population of monocyte-derived macrophages</article-title><source>Immunity</source><year>2014</year><volume>41</volume><fpage>465</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.08.006</pub-id><?supplied-pmid 25200712?><pub-id pub-id-type="pmid">25200712</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satpathy</surname><given-names>AT</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Albring</surname><given-names>JC</given-names></name><name><surname>Murphy</surname><given-names>KM</given-names></name></person-group><article-title>Re(de)fining the dendritic cell lineage</article-title><source>Nat Immunol</source><year>2012</year><volume>13</volume><fpage>1145</fpage><lpage>1154</lpage><pub-id pub-id-type="doi">10.1038/ni.2467</pub-id><?supplied-pmid 23160217?><pub-id pub-id-type="pmid">23160217</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Trezza CR, Kashuba ADM: Pharmacokinetics of antiretrovirals in Genital Secretions and Anatomic Sites of HIV Transmission: Implications for HIV Prevention. Clin Pharmacokinet. 2014.</mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revy</surname><given-names>P</given-names></name><name><surname>Sospedra</surname><given-names>M</given-names></name><name><surname>Barbour</surname><given-names>B</given-names></name><name><surname>Trautmann</surname><given-names>A</given-names></name></person-group><article-title>Functional antigen-independent synapses formed between T cells and dendritic cells</article-title><source>Nat Immunol</source><year>2001</year><volume>2</volume><fpage>925</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1038/ni713</pub-id><?supplied-pmid 11561183?><pub-id pub-id-type="pmid">11561183</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochweller</surname><given-names>K</given-names></name><name><surname>Wabnitz</surname><given-names>GH</given-names></name><name><surname>Samstag</surname><given-names>Y</given-names></name><name><surname>Suffner</surname><given-names>J</given-names></name><name><surname>H&#x000e4;mmerling</surname><given-names>GJ</given-names></name><name><surname>Garbi</surname><given-names>N</given-names></name></person-group><article-title>Dendritic cells control T cell tonic signaling required for responsiveness to foreign antigen</article-title><source>Proc Natl Acad Sci</source><year>2010</year><volume>107</volume><fpage>5931</fpage><lpage>5936</lpage><pub-id pub-id-type="doi">10.1073/pnas.0911877107</pub-id><?supplied-pmid 20231464?><pub-id pub-id-type="pmid">20231464</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Mitar</surname><given-names>I</given-names></name><name><surname>Sattentau</surname><given-names>QJ</given-names></name></person-group><article-title>Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>13916</fpage><lpage>13921</lpage><pub-id pub-id-type="doi">10.1128/JVI.01585-07</pub-id><?supplied-pmid 17913807?><pub-id pub-id-type="pmid">17913807</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seya</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Tsuji</surname><given-names>S</given-names></name><name><surname>Begum</surname><given-names>NA</given-names></name><name><surname>Nomura</surname><given-names>M</given-names></name><name><surname>Azuma</surname><given-names>I</given-names></name><name><surname>Hayashi</surname><given-names>A</given-names></name><name><surname>Toyoshima</surname><given-names>K</given-names></name></person-group><article-title>Two receptor theory in innate immune activation: studies on the receptors for bacillus Culmet Guillen-cell wall skeleton</article-title><source>Arch Immunol Ther Exp (Warsz)</source><year>2001</year><volume>49</volume><issue>Suppl 1</issue><fpage>S13</fpage><lpage>S21</lpage><pub-id pub-id-type="pmid">11603865</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groot</surname><given-names>F</given-names></name><name><surname>van Capel</surname><given-names>TMM</given-names></name><name><surname>Schuitemaker</surname><given-names>J</given-names></name><name><surname>Berkhout</surname><given-names>B</given-names></name><name><surname>de Jong</surname><given-names>EC</given-names></name></person-group><article-title>Differential susceptibility of na&#x000ef;ve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission</article-title><source>Retrovirology</source><year>2006</year><volume>3</volume><fpage>52</fpage><pub-id pub-id-type="doi">10.1186/1742-4690-3-52</pub-id><?supplied-pmid 16916447?><pub-id pub-id-type="pmid">16916447</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabado</surname><given-names>RL</given-names></name><name><surname>Babcock</surname><given-names>E</given-names></name><name><surname>Kavanagh</surname><given-names>DG</given-names></name><name><surname>Tjomsland</surname><given-names>V</given-names></name><name><surname>Walker</surname><given-names>BD</given-names></name><name><surname>Lifson</surname><given-names>JD</given-names></name><name><surname>Bhardwaj</surname><given-names>N</given-names></name><name><surname>Larsson</surname><given-names>M</given-names></name></person-group><article-title>Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1</article-title><source>Eur J Immunol</source><year>2007</year><volume>37</volume><fpage>1752</fpage><lpage>1763</lpage><pub-id pub-id-type="doi">10.1002/eji.200636981</pub-id><?supplied-pmid 17534864?><pub-id pub-id-type="pmid">17534864</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Lockhart</surname><given-names>M</given-names></name><name><surname>Rojas</surname><given-names>AV</given-names></name><name><surname>Fettis</surname><given-names>MM</given-names></name><name><surname>Bauserman</surname><given-names>R</given-names></name><name><surname>Higa</surname><given-names>TR</given-names></name><name><surname>Miao</surname><given-names>H</given-names></name><name><surname>Waugh</surname><given-names>RE</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name></person-group><article-title>T cell receptor signaling can directly enhance the avidity of CD28 ligand binding</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e89263</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0089263</pub-id><?supplied-pmid 24586641?><pub-id pub-id-type="pmid">24586641</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias-Ussel</surname><given-names>M</given-names></name><name><surname>Vandergeeten</surname><given-names>C</given-names></name><name><surname>Marchionni</surname><given-names>L</given-names></name><name><surname>Chomont</surname><given-names>N</given-names></name><name><surname>Romerio</surname><given-names>F</given-names></name></person-group><article-title>High levels of CD2 expression identify HIV-1 latently infected resting memory CD4<sup>+</sup> T cells in virally suppressed subjects</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>9148</fpage><lpage>9158</lpage><pub-id pub-id-type="doi">10.1128/JVI.01297-13</pub-id><?supplied-pmid 23760244?><pub-id pub-id-type="pmid">23760244</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Jarrossay</surname><given-names>D</given-names></name><name><surname>Facchetti</surname><given-names>F</given-names></name><name><surname>Alebardi</surname><given-names>O</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Lanzavecchia</surname><given-names>A</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group><article-title>Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon</article-title><source>Nat Med</source><year>1999</year><volume>5</volume><fpage>919</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1038/11360</pub-id><?supplied-pmid 10426316?><pub-id pub-id-type="pmid">10426316</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groot</surname><given-names>F</given-names></name><name><surname>van Capel</surname><given-names>TM</given-names></name><name><surname>Kapsenberg</surname><given-names>ML</given-names></name><name><surname>Berkhout</surname><given-names>B</given-names></name><name><surname>de Jong</surname><given-names>EC</given-names></name></person-group><article-title>Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition</article-title><source>Blood</source><year>2006</year><volume>108</volume><fpage>1957</fpage><lpage>1964</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-03-010918</pub-id><?supplied-pmid 16705088?><pub-id pub-id-type="pmid">16705088</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzionek</surname><given-names>A</given-names></name><name><surname>Fuchs</surname><given-names>A</given-names></name><name><surname>Schmidt</surname><given-names>P</given-names></name><name><surname>Cremer</surname><given-names>S</given-names></name><name><surname>Zysk</surname><given-names>M</given-names></name><name><surname>Miltenyi</surname><given-names>S</given-names></name><name><surname>Buck</surname><given-names>DW</given-names></name><name><surname>Schmitz</surname><given-names>J</given-names></name></person-group><article-title>BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood</article-title><source>J Immunol Baltim Md</source><year>1950</year><volume>2000</volume><issue>165</issue><fpage>6037</fpage><lpage>6046</lpage></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Doherty</surname><given-names>U</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Gezelter</surname><given-names>S</given-names></name><name><surname>Swiggard</surname><given-names>WJ</given-names></name><name><surname>Betjes</surname><given-names>M</given-names></name><name><surname>Bhardwaj</surname><given-names>N</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name></person-group><article-title>Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature</article-title><source>Immunology</source><year>1994</year><volume>82</volume><fpage>487</fpage><lpage>493</lpage><?supplied-pmid 7525461?><pub-id pub-id-type="pmid">7525461</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rappocciolo</surname><given-names>G</given-names></name><name><surname>Piazza</surname><given-names>P</given-names></name><name><surname>Fuller</surname><given-names>CL</given-names></name><name><surname>Reinhart</surname><given-names>TA</given-names></name><name><surname>Watkins</surname><given-names>SC</given-names></name><name><surname>Rowe</surname><given-names>DT</given-names></name><name><surname>Jais</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Rinaldo</surname><given-names>CR</given-names></name></person-group><article-title>DC-SIGN on B lymphocytes is required for transmission of HIV-1 to T lymphocytes</article-title><source>PLoS Pathog</source><year>2006</year><volume>2</volume><fpage>e70</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0020070</pub-id><?supplied-pmid 16839201?><pub-id pub-id-type="pmid">16839201</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porichis</surname><given-names>F</given-names></name><name><surname>Kaufmann</surname><given-names>DE</given-names></name></person-group><article-title>Role of PD-1 in HIV pathogenesis and as target for therapy</article-title><source>Curr HIV/AIDS Rep</source><year>2012</year><volume>9</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s11904-011-0106-4</pub-id><?supplied-pmid 22198819?><pub-id pub-id-type="pmid">22198819</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chomont</surname><given-names>N</given-names></name><name><surname>El-Far</surname><given-names>M</given-names></name><name><surname>Ancuta</surname><given-names>P</given-names></name><name><surname>Trautmann</surname><given-names>L</given-names></name><name><surname>Procopio</surname><given-names>FA</given-names></name><name><surname>Yassine-Diab</surname><given-names>B</given-names></name><name><surname>Boucher</surname><given-names>G</given-names></name><name><surname>Boulassel</surname><given-names>MR</given-names></name><name><surname>Ghattas</surname><given-names>G</given-names></name><name><surname>Brenchley</surname><given-names>JM</given-names></name><name><surname>Schacker</surname><given-names>TW</given-names></name><name><surname>Hill</surname><given-names>BJ</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name><name><surname>Routy</surname><given-names>JP</given-names></name><name><surname>Haddad</surname><given-names>EK</given-names></name><name><surname>Sekaly</surname><given-names>RP</given-names></name></person-group><article-title>HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation</article-title><source>Nat Med</source><year>2009</year><volume>15</volume><fpage>893</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1038/nm.1972</pub-id><?supplied-pmid 19543283?><pub-id pub-id-type="pmid">19543283</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parry</surname><given-names>RV</given-names></name><name><surname>Chemnitz</surname><given-names>JM</given-names></name><name><surname>Frauwirth</surname><given-names>KA</given-names></name><name><surname>Lanfranco</surname><given-names>AR</given-names></name><name><surname>Braunstein</surname><given-names>I</given-names></name><name><surname>Kobayashi</surname><given-names>SV</given-names></name><name><surname>Linsley</surname><given-names>PS</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name><name><surname>Riley</surname><given-names>JL</given-names></name></person-group><article-title>CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>9543</fpage><lpage>9553</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.21.9543-9553.2005</pub-id><?supplied-pmid 16227604?><pub-id pub-id-type="pmid">16227604</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitney</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>KY</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>XD</given-names></name><name><surname>Yang</surname><given-names>WP</given-names></name><name><surname>McKinnon</surname><given-names>M</given-names></name><name><surname>Longphre</surname><given-names>M</given-names></name></person-group><article-title>A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33</article-title><source>Eur J Biochem FEBS</source><year>2001</year><volume>268</volume><fpage>6083</fpage><lpage>6096</lpage><pub-id pub-id-type="doi">10.1046/j.0014-2956.2001.02543.x</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avril</surname><given-names>T</given-names></name><name><surname>Floyd</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>F</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name><name><surname>Crocker</surname><given-names>PR</given-names></name></person-group><article-title>The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells</article-title><source>J Immunol Baltim Md</source><year>1950</year><volume>2004</volume><issue>173</issue><fpage>6841</fpage><lpage>6849</lpage></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikehara</surname><given-names>Y</given-names></name><name><surname>Ikehara</surname><given-names>SK</given-names></name><name><surname>Paulson</surname><given-names>JC</given-names></name></person-group><article-title>Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>43117</fpage><lpage>43125</lpage><pub-id pub-id-type="doi">10.1074/jbc.M403538200</pub-id><?supplied-pmid 15292262?><pub-id pub-id-type="pmid">15292262</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bibollet-Ruche</surname><given-names>F</given-names></name><name><surname>McKinney</surname><given-names>BA</given-names></name><name><surname>Duverger</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>FH</given-names></name><name><surname>Ansari</surname><given-names>AA</given-names></name><name><surname>Kutsch</surname><given-names>O</given-names></name></person-group><article-title>The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype</article-title><source>J Virol</source><year>2008</year><volume>82</volume><fpage>10271</fpage><lpage>10278</lpage><pub-id pub-id-type="doi">10.1128/JVI.01319-08</pub-id><?supplied-pmid 18667496?><pub-id pub-id-type="pmid">18667496</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>DH</given-names></name><name><surname>Hurtado-Ziola</surname><given-names>N</given-names></name><name><surname>Gagneux</surname><given-names>P</given-names></name><name><surname>Varki</surname><given-names>A</given-names></name></person-group><article-title>Loss of Siglec expression on T lymphocytes during human evolution</article-title><source>Proc Natl Acad Sci</source><year>2006</year><volume>103</volume><fpage>7765</fpage><lpage>7770</lpage><pub-id pub-id-type="doi">10.1073/pnas.0510484103</pub-id><?supplied-pmid 16682635?><pub-id pub-id-type="pmid">16682635</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>PC</given-names></name><name><surname>Karris</surname><given-names>MY</given-names></name><name><surname>Spina</surname><given-names>CA</given-names></name><name><surname>Richman</surname><given-names>DD</given-names></name><name><surname>Varki</surname><given-names>A</given-names></name></person-group><article-title>Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells</article-title><source>J Mol Med Berl Ger</source><year>2013</year><volume>91</volume><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type="doi">10.1007/s00109-012-0951-7</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G-Y</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>CD24 and Siglec-10 selectively repress tissue damage-induced immune responses</article-title><source>Science</source><year>2009</year><volume>323</volume><fpage>1722</fpage><lpage>1725</lpage><pub-id pub-id-type="doi">10.1126/science.1168988</pub-id><?supplied-pmid 19264983?><pub-id pub-id-type="pmid">19264983</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandala-Sanchez</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Reinwald</surname><given-names>S</given-names></name><name><surname>Dromey</surname><given-names>JA</given-names></name><name><surname>Lee</surname><given-names>B-H</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>B&#x000f6;hmer</surname><given-names>RM</given-names></name><name><surname>Harrison</surname><given-names>LC</given-names></name></person-group><article-title>T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10</article-title><source>Nat Immunol</source><year>2013</year><volume>14</volume><fpage>741</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1038/ni.2610</pub-id><?supplied-pmid 23685786?><pub-id pub-id-type="pmid">23685786</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosse</surname><given-names>J</given-names></name><name><surname>Meier</surname><given-names>K</given-names></name><name><surname>Bauer</surname><given-names>TJ</given-names></name><name><surname>Eilles</surname><given-names>C</given-names></name><name><surname>Grimm</surname><given-names>D</given-names></name></person-group><article-title>Cell separation by countercurrent centrifugal elutriation: recent developments</article-title><source>Prep Biochem Biotechnol</source><year>2012</year><volume>42</volume><fpage>217</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1080/10826068.2011.602799</pub-id><?supplied-pmid 22509848?><pub-id pub-id-type="pmid">22509848</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>LJ</given-names></name><name><surname>Muench</surname><given-names>H</given-names></name></person-group><article-title>A simple method of estimating fifty per cent endpoints</article-title><source>Am J Epidemiol</source><year>1938</year><volume>27</volume><fpage>493</fpage><lpage>497</lpage></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pimentel</surname><given-names>H</given-names></name><name><surname>Kelley</surname><given-names>R</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biol</source><year>2013</year><volume>14</volume><fpage>R36</fpage><pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><?supplied-pmid 23618408?><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pop</surname><given-names>M</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title><source>Genome Biol</source><year>2009</year><volume>10</volume><fpage>R25</fpage><pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id><?supplied-pmid 19261174?><pub-id pub-id-type="pmid">19261174</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Pyl</surname><given-names>PT</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><article-title>HTSeq&#x02013;a Python framework to work with high-throughput sequencing data</article-title><source>Bioinforma Oxf Engl</source><year>2015</year><volume>31</volume><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname><given-names>CW</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>voom: precision weights unlock linear model analysis tools for RNA-seq read counts</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><fpage>R29</fpage><pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r29</pub-id><?supplied-pmid 24485249?><pub-id pub-id-type="pmid">24485249</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="other">Victorian bioinformatics consortium [Internet]. Monash University, Australia, 2014b. [Available from: <ext-link ext-link-type="uri" xlink:href="http://victorian-bioinformatics-consortium.github.io/degust/">http://victorian-bioinformatics-consortium.github.io/degust/</ext-link>]. Accessed August 2014.</mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="other">Dynamic Venn diagrams for Differential Gene Expression [Internet]. Dyn. Venn Diagr. Differ. Gene Expr. Monash University, Australia, 2014a. [Available from: <ext-link ext-link-type="uri" xlink:href="http://drpowell.github.io/vennt/">http://drpowell.github.io/vennt/</ext-link>]. Accessed August 2014.</mixed-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>AN</given-names></name><name><surname>Wilkinson</surname><given-names>J</given-names></name><name><surname>Bye</surname><given-names>CR</given-names></name><name><surname>Bosnjak</surname><given-names>L</given-names></name><name><surname>Stern</surname><given-names>JL</given-names></name><name><surname>Nicholle</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Cunningham</surname><given-names>AL</given-names></name></person-group><article-title>HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><fpage>7103</fpage><lpage>7113</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.10.7103</pub-id><?supplied-pmid 17082627?><pub-id pub-id-type="pmid">17082627</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>AN</given-names></name><name><surname>Kraus</surname><given-names>M</given-names></name><name><surname>Bye</surname><given-names>CR</given-names></name><name><surname>Byth</surname><given-names>K</given-names></name><name><surname>Turville</surname><given-names>SG</given-names></name><name><surname>Tang</surname><given-names>O</given-names></name><name><surname>Mercier</surname><given-names>SK</given-names></name><name><surname>Nasr</surname><given-names>N</given-names></name><name><surname>Stern</surname><given-names>JL</given-names></name><name><surname>Slobedman</surname><given-names>B</given-names></name><name><surname>Driessen</surname><given-names>C</given-names></name><name><surname>Cunningham</surname><given-names>AL</given-names></name></person-group><article-title>HIV-1&#x02013;infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-12-194845</pub-id><?supplied-pmid 19436054?><pub-id pub-id-type="pmid">19436054</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="other">DAVID Bioinformatics resources 6.7 [Internet]. Database Annot. Vis. Integr. Discov., National Institute of Allergy and Infectious Diseases (NIAID), NIH, USA, 2015. [Available from: <ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov">http://david.abcc.ncifcrf.gov</ext-link>]. Accessed in August 2014.</mixed-citation></ref></ref-list></back></article>